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Traditional Chinese medicines (TCM) may provide possible alternatives for 
treatment of asthma. A previous study in our department has shown that a novel 
Chinese herbal formula CUF2 has beneficial anti-inflammatory effects in a rat model 
of asthma and limited studies have shown that four of the five ingredients of CUF2 
contributed to the beneficial effects. The objective of the present study was to 
examine the anti-inflammatory and anti-asthmatic effects of the four ingredients 
(Huang Qi，Bai Bu，Chuan Bei, Huang Qin) in a HDM-induced rat model of asthma. 
The fifth ingredient Dong Chong Cao was excluded in the present study since our 
preliminary studies on this herb gave unsatisfactory results. In addition, another herb 
extract, Kuan Dong Hua which has been confirmed by a recent report to have 
anti-inflammatory effects in a well-designed clinical trial was also studied in the 
same manner. 
In the first part of this study, we attempted to establish an animal model of 
HDM-induced asthma in SD rats. In this model, we showed that repeated allergen 
exposures induced allergic inflammation with characteristics of human disease. Total 
inflammatory cells and eosinophils in BALF were significantly increased in the 
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asthma group compared with control. Consistently, lung histology showed 
accumulation of inflammatory cells, eosinophil infiltration and goblet cell 
hyperplasia in the asthma group. Moreover, increased production of cytokines and 
chemokine (IL-4，IL-6, IL-10, TNF-a, IFN-y and MCP-1) in BALF was observed in 
the asthma group. These results indicated that an asthma model could be established 
in SD rats using HDM. This model may facilitate further drug trial in asthma. 
The next part of this study was to investigate the effects of the aforementioned 
five herbs using this asthma model. The study showed that Huang Qi, Bai Bu, Huang 
Qin and Kuan Dong Hua did not significantly reduce the total cell number and 
eosinophils in BALF. Chuan Bei significantly reduced total cell count, but not 
eosinophil count. Similarly, no effects were observed with any of the herbs on the 
pulmonary inflammatory cells, pulmonary eosinophilia and goblet cell hyperplasia. 
However, we found that Kuan Dong Hua exerted potent inhibitory effects on 
cytokine production in BALF and significantly inhibited IL-4, IL-6, IL-10 and 
MCP-1. Huang Qi and Bai Bu exhibited similar inhibitory effects on IL-4 and IL-6, 
although not reaching statistical significance. Chuan Bei and Huang Qin significantly 
inhibited MCP-1 and IL-10 respectively. In conclusion, our results suggest that these 
herbs when used individually at the present dosage could not elicit significant 
histological changes of the lung and the cell count in BALF. They however were 
capable of inhibiting the production of different inflammatory cytokines and 
chemokine in the rat model of asthma. 
Furthermore, the in vitro study showed that Kuan Dong Hua significantly 
inhibited PMA plus A23187-induced production of pro-inflammatory cytokines (IL-8, 
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GM-CSF and TNF-1) in cultured human mast cells. Together, these studies indicated 
that Kuan Dong Hua may have therapeutic potential in the treatment of asthma. 
iii 























Abstract (Chinese version) 












I would like to express my sincere thanks to my supervisor, Prof. Y. T. Sung, for 
her patient guidance, invaluable advice, and continuous encouragement and care 
throughout the entire period of study. Without her helpful comments, it is impossible 
to finish up my research work. 
I would also like to thank all my colleagues of the Department of Pediatrics at 
the Prince of Wales Hospital for their suggestions, encouragements and kindness. 
Thanks should also go to the staffs of the Lee Hysan Clinical Research Laboratories 
for providing a good research environment during the course of my research study. 
In addition, I wish to thank all the staffs of the Institute of Chinese Medicine at 
the Chinese University of Hong Kong for providing supports to my research. Special 
thanks are given to Ms. K. M. Lee and Ms. F.C. Lam of the Institute of Chinese 
Medicine for assisting me in part of my laboratory works. 
Finally, I wish to thank Prof. W. Y. Chan of the Department of Anatomy of the 
Chinese University of Hong Kong for his technical assistance and allowing me to use 
the laboratory and facilities for performing the histological study. 
Last but not least, I want to express my deepest gratitude to my family and 
friends for their greatest love, encouragement and support. They give me strength 
during my study and the completion of this thesis. 
vi 
Acknowledgements 
The work described in this thesis was substantially supported by a grant from 
the University Grants Committee of the Hong Kong Special Administrative Region, 
China under the Area of Excellence project "Chinese Medicine Research and Further 
Development" (Project No.: AoE/B-10/01) coordinated by the Institute of Chinese 
Medicine, The Chinese University of Hong Kong. 
vii 
Table of Contents 
TABLE OF CONTENTS 
ABSTRACT (ENGLISH VERSION) i 
ABSTRACT (CHINESE VERSION) iv 
ACKNOWLEDGEMENTS vi 
TABLE OF CONTENTS viii 
LIST OF TABLES AND FIGURES xii 
ABBREVIATIONS xiv 
CHAPTER 1. GENERAL INTRODUCTION 1 
1.1 Definition of asthma 1 
1.2 Asthma epidemiology 2 
1.3 Pathogenesis of Asthma 3 
1.3.1 Gene-environment interaction 3 
1.3.2 Allergens and atopic sensitization 4 
1.3.3 Other environmental factors 5 
1A House dust mite (HDM) 5 
1.4.1 Characteristics of HDM allergens 5 
1.4.2 HDM and asthma 6 
1.5 Pathophysiology of asthma 8 
1.5.1 Airway inflammation 8 
1.5.1.1 Cellular mechanism 8 
1.5.1.2 Characteristics of chronic inflammation 9 
1.5.1.3 Inflammatory cells in airway inflammation 10 
1.5.1.3.1 Mast cell 10 
1.5.1.3.2 Macrophages 11 
1.5.1.3.3 Tlymphocytes 12 
1.5.1.3.4 Eosinophils 12 
1.5.1.3.5 Epithelial cells 13 
1.5.1.4 Cytokines in asthma 14 
1.5.1.4.1 Inflammatory cytokines 14 
1.5.1.4.1.1 Interleukin-4 14 
1.5.1.4.1.2 Interleukin-5 14 
1.5.1.4.1.3 Interleukin-6 15 
viii 
Table of Contents 
1.5.1.4.1.4 Granulocyte Monocyte Colony Stimulating 
Factor (GM-CSF) 15 
1.5.1.4.1.5 Tumor Necrosis Factor- a (TNF- a) 16 
1.5.1.4.2 Anti-inflammatory cytokines 17 
1.5.1.4.2.1 Interleukin-10 17 
L 5.1.4.2.2 Interferon-y (IFN-y) 17 
1.5.2 Airway hyperresponsiveness (AHR) 18 
1.5.3 A irway remodeling 19 
1.6 Asthma therapy 21 
1.6.1 P2-cigonists 21 
1.6.2 Cromolyn and nedocromil 21 
1.6.3 Theophylline 22 
1.6.4 Leukotriene modifiers 22 
1.6.5 Corticosteroids 23 
1.7 Traditional Chinese Medicine 24 
1.7.1 Introduction 24 
1.7.2 Traditional Chinese Medicine (TCM) 24 
1.7.3 Chinese herbal formula, CU Formula 2 (CUF2) and Kuan Dong Hua 
26 
1.8 Objectives of our studies 28 
CHAPTER 2. ESTABLISHMENT OF A HDM-INDUCED ASTHMATIC 
ANIMAL MODEL IN SD RATS 32 
2.1 Introduction 32 
2.2 Materials and methods 33 
2.2.1 Buffers and solutions 33 
2.2.2 Animals 33 
2.2.3 Preparation of aluminum hydroxide gel 34 
2.2.4 HDMAllergen 34 
22.5 Sensitization Procedure 35 
2.2.6 Intratracheal instillation challenge 35 
2.2.7 Bronchoalveolar lavage (BAL) and BAL Cell counting 36 
2.2.8 Lung Histopathological Analysis 37 
2.2.9 Measurement of cytokine and chemokine by Enzyme-Linked 
Immunosorbent Assay (ELISA) 39 
2.2.J0 Statistical Analysis 40 
2.3 Results 41 
2.3.1 Cellular Analysis ofBALF 41 
ix 
Table of Contents 
2.3.2 Histopathology 42 
2.3.3 Cytokine and chemokine 43 
2.4 Discussion 44 
CHAPTER 3. IMMUNOMODULATORY EFFECT OF CUF2 AND 
KUAN DONG HUA IN A RAT MODEL OF HDM-INDUCED ASTHMA 
65 
3.1 Introduction 65 
3.2 Materials and methods 67 
3.2.1 Herbal materials and extraction method 67 
3.2.2 Antigen sensitization, challenge, and treatment 68 
3.2.3 Bronchoalveolar lavage and cell differential counts 69 
3.2.4 Histological Studies 69 
3.2.5 Measurement of BALF cytokines and chemokines 70 
3.2.6 Body weight, thymus index and spleen index 70 
3.2.7 Statistical analysis 70 
3.3 Results 71 
3.3.1 Effect of herbs and DXA on total cells and eosinophils in BALF..... 71 
3.3.2 Effect of herb and DXA on lung histology 72 
3.3.3 Effect of herbs and DXA on cytokine and chemokine level in BALF 73 
3.3.4 Effect of herb and DXA on body weight, thymus index and spleen 
index 75 
3.4 Discussion 77 
CHAPTER 4. IMMUNOMODULATORY EFFECT OF KUAN DONG 
HUA ON HUMAN MAST CELLS (HMC-1) 109 
4.1 Introduction 109 
4.2 Materials and methods 110 
4.2.1 Reagents 110 
4.2.2 Cell line and Cell Culture Ill 
4.2.3 Herb and extraction procedure I l l 
4.2.4 Cell Viability Assay 112 
4.2.5 Assay of cytokine secretion 113 
4.2.6 Quantitative Analysis of cytokines 113 
4.2.7 Bacterial endotoxin contamination 114 
4.2.8 Statistical analysis 115 
4.3 Results 116 
4.3.1 Effect of Kuan Dong Hua on cell viability of HMC-1 116 
X 
Table of Contents 
4.3.2 Effect of Kuan Dong Hua on cytokine release from HMC-1 116 
4.3.3 Effect of endotoxin contamination in the extract 117 
4.4 Discussion 118 
CHAPTER 5. GENERAL CONCLUSION 125 
5.1 Conclusion 125 
5.2 Limitations of this study and Future work 128 
REFERENCES 130 
APPENDICES 145 
Appendix A. Wright-Giemsa Stain for cytospin preparations 145 
Appendix B. Hematoxylin & eosin (H&E) staining 145 
Appendix C. Congo Red staining 146 
Appendix D. Periodic acid-Schiff (PAS) staining 146 
xi 
List of Tables and Figures 
LIST OF TABLES AND FIGURES 
Table 1-1. Recent studies of Chinese herbal medicine in animal model of asthma 
29 
Table 3-1. The voucher specimen numbers and extraction efficiencies of the five 
herbs used in the present study 85 
Figure 1-1. Cellular interactions in asthma 30 
Figure 1-2. Illustration of the herb components of CUF2 (Huang Qi, Bai Bu, 
Chuan Bei, Dong Chong Xia Cao and Huang Qin) and Kuan Dong 
Hua 31 
Figure 2-1. Steps for intratracheal instillation 49 
Figure 2-2. Bronchoalveolar lavage (BAL) Sampling 50 
Figure 2-3. Cellular composition of BALF after HDM challenges 52 
Figure 2-4. Representative micrographs of cytospin preparations of BALF at 24 h 
after (A) saline (naive) or (B) HDM challenges 54 
Figure 2-5. Histopathologic changes in HDM-challenged rats 56 
Figure 2-6. Histological analysis of lung sections stained with Congo Red 58 
Figure 2-7. Histological analysis of lung sections stained with PAS for goblet 
cells 61 
Figure 2-8. Effect of exposure to HDM or saline on (A) inflammation score, (B) 
lung eosinophil number and (C) goblet cell score 62 
Figure 2-9. Effect of saline and HDM challenges on (A) IL-4，(B) IFN-y, (C) 
IL-10 (D) IL-6, (E) TNF-a and (F) MCP-1 levels in BALF 64 
Figure 3-1. Experimental protocol 84 
Figure 3-2. Effect of herb and DXA treatment on (A) total leukocyte and (B) 
eosinophil numbers in BALF 48 h after the last challenge in sensitized 
rats 87 
xii 
List of Tables and Figures 
Figure 3-3. Results of inflammation scores from different groups of rats 88 
Figure 3-4. Effect of herb and DXA treatment on eosinophil accumulation in the 
bronchial wall 89 
Figure 3-5. Results of goblet cell score from different groups of rats 90 
Figure 3-6. Representative H&E stained lung sections from different treatment 
groups of rats 93 
Figure 3-7. Representative Congo Red stained lung sections from different 
treatment groups of rats 98 
Figure 3-8. Representative PAS stained lung sections from different treatment 
groups of rats 101 
Figure 3-9. Effect of herb and DXA treatment on IL-4 in BALF 48 h after the last 
challenge in sensitized rats 102 
Figure 3-10. Effect of herb and DXA treatment on IL-6 in BALF 48 h after the last 
challenge in sensitized rats 103 
Figure 3-11. Effect of herb and DXA treatment on IL-10 in BALF 48 h after the 
last challenge in sensitized rats 104 
Figure 3-12. Effect of herb and DXA treatment on IFN-y in BALF 48 h after the 
last challenge in sensitized rats 105 
Figure 3-13. Effect of herb and DXA treatment on MCP-1 in BALF 48 h after the 
last challenge in sensitized rats 106 
Figure 3-14. Effect of herb and DXA treatment on (A) body weight, (B) thymus 
index and (C) spleen index of HDM challenged rats 108 
Figure 4-1. Effect of Kuan Dong Hua on the viability ofHMC-1 cells 121 
Figure 4-2. Inhibitory effects of Kuan Dong Hua extract at concentrations of 0.625, 
1.25 and 2.5 mg/ml on the PMA plus A23187-stimulated (A) IL-6, (B) 





°C degree Celsius 
A23187 calcium ionophore A23187 
AC allergen challenge 
AHR airway hyperresponsiveness 
A1(0H)3 aluminium hydroxide 
ANOVA analysis of variance 
APC antigen-presenting cells 
BAL bronchoalveolar lavage 
BALF bronchoalveolar lavage fluid 
BHR bronchial hyperresponsiveness 
BN rat Brown Norway rat 
CAM complementary and alternative medicines 
CUF2 CU Formula 2 
DEAE diethylaminoethyl 
EDTA ethylenediaminetetraacetic acid 
Der f Dermatophagoides farinae 
Der p Dermatophagoides pteronyssinus 
DMSO dimethyl sulfoxide 
DXA dexamethasone 
EAR early phase response 
ECM extracellular matrix 
ELISA enzyme-linked immunosorbent assay 
EU endotoxin unit 
FBS fetal bovine serum 
g gram 
GM-CSF granulocyte monocyte colony stimulating factor 
h hour 
HDM house dust mites 
HMC human mast cell 
H&E hematoxylin and eosin 
HPF high-power-field 






IMDM Iscove's Modified Dulbecco's Medium 
i.p. intraperitoneal(ly) 
ISAAC International Study of Asthma and Allergies in 
Childhood 
kg kilogram (10^ gram) 
L liter 
LAL Limulus amoebocyte lysate 
LAR late phase response 
LO lipoxygenase 
LSD least significant difference 
LT leukotrienes 
M molar 
MCP-1 monocyte chemotactic protein-1 
mg milligram (10'^ gram) 
min minute 
MIP-1 a macrophage inflammatory protein-1 a 
ml milliliter (10'3 liter) 
mm millimeter ( 1 m e t e r ) 
mM millimolar ( 1 m o l a r ) 
MMP matrix metalloproteinase 
MTT 3-(4,5-dimethylthiazol-2-yl)-diphenyltetrazolium 
bromide 
NBF neutral buffered formalin 
ng nanogram (10-9 gram) 
NO nitric oxide 
PAS periodic acid-schiff 
PBMC peripheral blood mononuclear cell 
PBS phosphate-buffered saline 
pg picogram (10''^ gram) 
PG prostaglandins 
PMA phorbol 12-myristate 13-acetate 
PMB polymyxin B sulfate 
RANTES regulated on activation, normal T-cells expressed and 
secreted 




SD rat Sprague-Dawley rat 
SD standard deviation 
SEM standard error of the mean 
TCM Traditional Chinese Medicine 
TGF-p transforming growth factor-p 
Thl /Th2 T helper type-1 / 2 
TMB 3,3',5,5'-tetramethylbenzidine 
TNF-a tumor necrosis factor-a 
U unit 
VCAM-1 vascular cell adhesion molecule-1 
v/v volume by volume 
w/v weight by volume 
w/w weight by weight 
|ig microgram ( 1 g r a m ) 
\x\ microliter (10'^ liter) 





1.1 Definition of asthma 
Asthma is a common chronic respiratory disease. There are no uniformly 
accepted definitions of asthma (Makino et al.，2000a). The definition from the Global 
Strategy for Asthma Management and Prevention Report published by World Health 
Organization and National Heart, Lung, and Blood Institute (WHO/NHLBI, 1995) 
stated that asthma is a chronic inflammatory disease of the airways in which many 
cell types play a role, in particular, mast cells, eosinophils, T lymphocytes, 
neutrophils and epithelial cells. In susceptible individuals, the inflammation causes 
recurrent episodes of wheezing, breathlessness, chest tightness and cough 
particularly at night and/or in the early morning. These symptoms are usually 
associated with widespread but variable airflow obstruction that is often reversible 
either spontaneously or with treatment. The inflammation also causes an associated 
increase in airway responsiveness to a variety of stimuli. 
The definition summarizes that airway inflammation is associated with airway 
hyperresponsiveness (AHR) and variable airflow limitation, which collectively leads 
to the clinical symptoms of asthma. Airway inflammation produces airflow limitation 
as a result of bronchoconstriction, airway edema, accumulation of mucus secretion, 
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and in some patients, airway remodeling (Makino et al, 2000b). AHR, an 
exaggerated bronchoconstrictor response to a variety of stimuli, is a physiologic 
characteristic of asthma. It is also thought to be closely linked to airway 
inflammation. The importance of airway inflammation in contribution to asthma will 
be discussed further in the later sections. Most of these changes are reversible. 
However, patients with chronic disease often show signs of airway 'remodeling', 
which is a primary cause of the development of irreversible airflow limitation and 
AHR (Makino et al., 2000a). 
1.2 Asthma epidemiology 
Asthma is one of the most common chronic diseases in the world, and is more 
common in Western countries and less common in developing countries (Beasley et 
al., 2000). Reports recently published showed there is a pattern of increase in asthma 
prevalence worldwide in the past few decades (Beasley et al., 2000; Masoli et al., 
2004; Eder et al” 2006; Asher et al” 2006). They showed that asthma has become 
more common in both children and adults around the world. The recent data (Asher 
et al., 2006) from the International Study of Asthma and Allergies in Childhood 
(ISAAC) phase 3 showed that since the mid-1990s, the prevalence of asthma 
symptoms increased in many centers throughout the world, although the prevalence 
of asthma symptoms remained unchanged or decreased in centers with existing high 




According to ISAAC phase 1 (during 1994/95) and phase 3 (during 2001/02) 
studies and the earlier surveys conducted, asthma prevalence is also increasing in 
Hong Kong over the past two decades. The prevalence rates of asthma in Hong Kong 
increased from 6.6% in 1992 to 11.2% in 1995 (Leung and Ho, 1994; Leung et al., 
1997) and decreased to 10.2% in 2002 (Wong et a!., 2004) in schoolchildren aged 
13-14 years. The prevalence rates of wheeze in the past year had increased 
dramatically from 3.7% in 1992 to 12.4% in 1995 (Leung et al, 1997; Wong et al, 
2004). Since 1995, the prevalence rates of asthma remained unchanged and 
furthermore, the prevalence of asthma symptoms in schoolchildren aged 13-14 years 
has decreased significantly as shown in a recent study by Wong et al. (2004). Despite 
the declining asthma prevalence in the previous years, the problem of asthma is still 
significant in Hong Kong that affects about 10% of schoolchildren (Asher et al., 
2006). 
1.3 Pathogenesis of Asthma 
1.3.1 Gene-environment interaction 
The causes of asthma remain unclear. Yet it is clear that asthma is a complex 
genetic disease that results from the interaction of a background of genetic 
susceptibility and a variety of environmental factors (Halonen and Stern, 2006). 
There is major hereditary contribution to the causes of asthma. Family history of 
asthma is strongly associated to asthma development in the later life. Besides, atopy 
is often associated with asthma. Atopy is a predisposition to the production of 
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Immunoglobulin (Ig)E antibodies on exposure to environmental allergens, and can be 
detected by skin-prick test to allergens or specific serum IgE levels (Makino et al., 
2000c). Although the genetic susceptibility of individual is important, asthma is 
without manifestations at birth and symptoms often develop in the first few years of 
life. Thus, there is an influence of environmental factors in early life before the 
inception of disease (Wong et al” 2006). A number of environmental factors have 
been identified to increase the risk of developing asthma. 
1.3,2 Allergens and atopic sensitization 
Allergens are important environmental factors in the pathogenesis of asthma and 
its persistence. The way in which exposure to allergens (e.g., mites, insects, molds, 
trees, pollens, grasses, animal dander) contributes to asthma involves initially, a 
process of sensitization, in which there is a formation of allergen-specific IgE 
antibody in a genetically predisposed (atopic) individual (Lemanske and Busse, 
2003). Continued exposure of sensitized individuals to the allergens produces 
inflammation of the lungs with resulting bronchial hyperreactivity, and leads to 
symptoms of asthma (Duff and Platts-Mills, 1992). Sensitization may take years of 
exposure and does not usually occur until 2 to 3 years of life. Thus, asthma induced 
by allergen is uncommon in the first year of life but develops in latter childhood and 
adolescence and peaks in the second decade of life (Lemanske and Busse, 2003). 
Once atopic individuals are sensitized, IgE-mediated reactions contribute both to 
acute asthma symptoms and chronic airway inflammation. Allergic sensitization is 
considered to an important risk factor for the development of asthma. Studies showed 
that sensitization to particular allergens, such as house dust mites (HDM), 
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cockroaches, cat-derived allergens, and molds, especially Alternaria, was strongly 
associated with development of asthma (Nelson, 2000). 
1.3,3 Other environmental factors 
In addition to exposure to allergen, a number of environmental factors are 
associated with an increased risk of asthma (reviewed by Wong et al” 2006; Eder et 
al” 2006; Lemanske and Busse, 2003; Beasley et cd., 2000). For example, viral 
respiratory tract infections are potent triggers of exacerbations of asthma. Respiratory 
syncytial virus and rhinoviruses are most common viruses associated with asthma in 
children (Busse and Gern, 1997). Besides, there is a hypothesis that the development 
of asthma is due in part to a reduction in childhood infections (e.g. measles, 
tuberculosis, hepatitis A) as well as exposure to microbial agents. Increased use of 
antibiotics, immunization and smaller family size are also risk factors for the 
development of asthma that may be related to a reduction in childhood infections. 
Furthermore, obesity and dietary factors, as well as maternal nutrition during 
pregnancy have been implicated in the development of asthma. 
1.4 House dust mite (HDM) 
1,4.1 Characteristics of HDM allergens 
HDM is a major source of indoor allergens in most areas of the world 
(Eggleston and Bush, 2001). The most common species of mites in homes worldwide 
5 
Chapter 1 
are D farinae and D pteronyssinus, which belong to the genus Dermatophagoides 
(Arlian and Platts-Mills, 2001). Mite allergens are divided into specific groups based 
on their biochemical composition, sequence homology and molecular weight. There 
are two major groups of allergens from D pteronyssinus and D farinae to which 
humans are most frequently sensitized (Roche et al., 1997). The group 1 allergens 
(Der p 1 & Der f 1) are 25-kD glycoproteins with cysteine protease activity which 
are digestive enzyme of the mite that secreted into feces (Duff and Platts-Mills, 
1992). The group 2 allergens (Der p 2 & Der f 2) are 14-kd nonglycosylated proteins 
that have high sequence homology. The protease activity of Der p 1 has been shown 
to contribute to the pathogenesis of asthma (Roche et al,, 1997). The cysteine 
protease activity of Der p 1 was found to disrupt the tight-junctions between 
epithelial cells, and leads to desquamation of the epithelial layer that facilitates the 
passage of allergens across the epithelium to dendritic cells (Wan et al, 1999). 
Moreover, the protease activity of Der p 1 was shown to induce the release of 
proinflammatory cytokines, such as IL-6 and IL-8, from epithelial cells which have a 
role in airway inflammation (King et cd., 1998; Asokananthan et al, 2002). 
1,4,2 HDM and asthma 
It is believed that exposure to high levels of HDM during early childhood 
contributes to both the development of sensitization and asthma (Platts-Mills et al., 
1997). Many studies around the world showed an increased prevalence of HDM 
sensitization among patients with asthma (Platts-Mills and de Week, 1989). HDM 
sensitization is considered to be an important risk factor for the development of 
asthma. There is increasing evidence for the association of HDM sensitization and 
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asthma. Some previous studies showed that allergic sensitivity to HDM, 
demonstrated by positive skin test to HDM, was associated with bronchial 
hyperresponsiveness (BHR) (Wong et al, 2002) and wheezing in children 
(Henderson et al” 1995; Wong et al, 2002). The study by Peat et al (1994) also 
revealed that HDM sensitization is a major risk factor for childhood asthma. They 
found that wheezing, recent asthma medication and urgent medical visits for the 
treatment of asthma symptoms, as well as BHR were correlated with a positive skin 
test to HDM and were most frequent in children with marked skin reactivity to HDM. 
For the relationship between exposure to HDM allergen and asthma, some studies 
demonstrated that the severity of asthma symptoms in affected children was 
correlated with the level of HDM exposure (Zock et al., 1994; Chan-Yeung et al., 
1995). In addition, the influence of HDM exposure in early childhood on the 
subsequent development of asthma was shown in several studies. Sporik et al (1990) 
showed that exposure to high levels of HDM allergens (>10 |ig per gram of dust) at 1 
year of age was associated with an increased risk of developing asthma at 11 years of 
age. Moreover, the age of onset of wheezing was shown to be inversely related to the 
level of HDM exposure. Besides, some other studies showed that elimination of 
HDM exposure produced an improvement in symptoms and lung function in 
sensitive children and adults, as well as a reduction of BHR and airway inflammation 
(reviewed by Nelson, 2000). In summary, these findings confirm that exposure to 
HDM is a risk factor for asthma. Exposure to high levels of HDM allergens could 
lead to asthma symptoms and increase asthma severity. 
7 
Chapter 1 
1.5 Pathophysiology of asthma 
L 5.1 Airway inflammation 
1.5.1.1 Cellular mechanism 
In the episode of allergic asthma, the airway response caused by allergen 
challenge consists of an early and a late response. An early phase response (EAR) is 
elicited when allergens bind to IgE on the surface of mast cells to activate them 
(Figure 1-1). This leads to a rapid release of inflammatory mediators, such as 
histamine, prostaglandins (PG) and leukotrienes (LT), which cause bronchi smooth 
muscle contraction, blood vessel dilatation, and mucous secretion (Bousquet et al.’ 
2000; Ferreira, 2004). They also induce microvascular leakage with exudation of 
plasma into the airways that results in edema in the airway wall. Together, these 
changes contribute to airway narrowing and airflow obstruction, and a drop in 
respiratory function is observed. These changes are transient and can be reversed by 
using bronchodilators such as p 2 - a g o n i s t s . 
The EAR is usually followed by a late phase response (LAR), which occurs 
around 4-6 hours after allergen challenge. The LAR is characterized by inflammatory 
events involving eosinophil activation and release of proinflammatory mediators. 
The late phase response is initiated by antigen-presenting cells (APC) (in particular 
dendritic cells which act as effective APC) which present the allergen to the naive 
helper T cells in the lymph nodes, and leads to their activation and differentiation 
into T helper cells (Th)2-type (Figure 1-1). They then migrate to the airway under 
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the signals of chemokines [e.g. macrophage inflammatory protein (MlP) - l a， 
"regulated on activation, normal T-cells expressed and secreted" (RANTES)] and 
once recruited into the airway, the CD4+ T helper cells function to orchestrate the 
inflammatory process in the late phase response (Bousquet et al., 2000; Ferreira, 
2004). They promote IgE synthesis by B cells through the release of IL-4 and IL-13 
(Ferreira, 2004). They also release cytokines that are critical in the activation, 
recruitment and survival of eosinophils, and survival of mast cell in the airways. The 
release of IL-5 stimulates eosinophil production in bone marrow, and IL-5 acting 
with IL-3，GM-CSF, RANTES enhances the migration of eosinophils from the 
circulation to the airway (Hamid et al., 2003). As a result, activated eosinophils, 
neutrophils, mast cells and T cells migrate to the airways causing inflammation. The 
mediators released by these cells lead to smooth muscle contraction, vasodilatation, 
plasma exudation and mucus secretion similar to the EAR, with the result of airway 
obstruction (Ferreira, 2004). However, in contrast to EAR, these effects can persist 
for several hours and causes a longer drop in respiratory functions compared with 
EAR. In addition, there is usually an increase in airway hyperresponsiveness after the 
LAR but not after the EAR. 
1,5,1.2 Characteristics of chronic inflammation 
Asthma is a chronic inflammatory disease of the airways. Airway inflammation 
is now recognized as the underlying pathogenic mechanism of asthma and involves a 
variety of cells and mediators (WHO/NHLBI, 1995; Bousquet et al, 2000). Patients 
who die of asthma have marked inflammation and pathological changes in the lungs. 
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The airway lumen is occluded by tenacious mucus plugs composed of plasma 
proteins exuded from airway vessels and mucus glycoproteins secreted by epithelial 
cells (Barnes, 1996). Moreover, epithelium damage and shedding is found and 
clumps of sloughed epithelial cells are present in the airway lumen. Other changes 
such as increase in goblet cells, basement membrane thickening, and smooth muscle 
hypertrophy and hyperplasia are observed in asthmatic airways. The airway wall is 
edematous and infiltrated with inflammatory cells. In addition, biopsies in asthmatic 
patients showed that increased numbers and activation of mast cells, eosinophils, 
macrophages and T lymphocytes are found in the airways (Barnes, 1996). Similarly, 
studies of bronchoalveolar lavage (BAL) in patients with active asthma have 
demonstrated increased numbers of lymphocytes, mast cells and eosinophils (Barnes, 
1996，2002; Rosenwasser, 2000). These cells are known to contribute to the 
inflammatory events by releasing their mediators. There is evidence that the degree 
of inflammation is correlated with the degree of AHR in asthmatic patients (Bames, 
1996; Rosenwasser, 2000). Increased AHR is a characteristic of asthma and the 
degree of AHR is correlated with the symptoms of asthma. 
1.5.1.3 Inflammatory cells in airway inflammation 
1.5.1,3.1 Mast cell 
Mast cells are important in the initiation of an acute response to allergen 
(Figure 1-1). They interact with allergen via the IgE bound to their high-affinity 
surface receptor FceRI, leading to the rapid release of pre-formed mediators such as 
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histamine, tryptase, PGD2 and cysteinyl leukotrienes (Hamid et al., 2003). These 
products are known to cause bronchoconstriction and alter vascular permeability that 
results in edema. Mast cell numbers are elevated and usually degranulated in the 
airway of asthmatic patients (Lordan and Holgate, 1999). In addition, mast cells also 
participate in the chronic inflammatory response through the release of 
multifunctional cytokines. The bronchial biopsy specimens from asthmatic patients 
show there is a positive immunostaining of IL-4, IL-5, IL-6, GM-CSF and TNF-a in 
mast cells (Barnes, 2002; Hamid et al.’ 2003). 
1.5.1.3.2 Macrophages 
Alveolar macrophages may also act as APC for presentation of allergen to T 
lymphocytes, although macrophages in the airway are far less effective in this way 
(Holt, 1993). Macrophages normally have a suppressive effect on lymphocyte 
function, but the effect may be retarded in asthma after allergen exposure (Barnes, 
1996). On the other hand, macrophages may also participate in airway inflammation 
by releasing a wide range of mediators and cytokines. They are activated by allergen 
through the low-affinity IgE receptors to release platelet-activating factors, bioactive 
lipids such as leukotrienes (LT) and cyclooxygenase products, reactive oxygen 
speices and nitric oxide and nitrites (Hamid et al., 2003; Rosenwasser, 2000). These 
products may have important effects on smooth muscle contraction, vascular 
permeability and on bronchial epithelial cells. In addition, proinflammatory 
cytokines produced by macrophages, such as IL-1，TNF-a, IL-6, IL-8 and GM-CSF 
may induce endothelial cell activation, cellular recruitment, and prolonged eosinophil 
survival (Hamid et al” 2003). 
11 
Chapter 1 
1.5.1.3.3 T lymphocytes 
T lymphocytes play a role in orchestrating the inflammatory response in asthma 
through the release of cytokines that results in recruitment, activation and survival of 
eosinophils. There is an increase in activated T helper (CD4+) lymphocytes present 
in bronchial biopsies and BAL fluid of asthma patients (Barnes, 2002; Rosenwasser, 
2000). The numbers of activated T cells in BAL fluid has been shown to correlate 
with the number of eosinophils in BAL fluid, as well as severity of symptoms and the 
degree of BHR (Barnes, 2002; Hamid et a/.，2003). T helper lymphocytes are 
classified into Thl and Th2 cells, depending on the types of cytokines released. Th2 
cells release a pattern of cytokines, such as IL-4, IL-5, IL-9 and IL-13 that contribute 
to airway inflammation. 
1.5.1.3.4 Eosinophils 
Eosinophils are the most characteristic cells found in asthma. They contribute to 
the pathology of the disease by the release of cytotoxic and proinflammatory 
mediators. Activated eosinophils release reactive oxygen species, highly toxic 
granule proteins including major basic protein, eosinophil cationic protein, 
eosinophil peroxidase, and eosinophil-derived neurotoxin, as well as cytokines and 
phospholipid-derived mediators (Hamid et al., 2003). The eosinophil granule 
proteins have been shown to damage the epithelium and cause epithelial shedding. 
These products contract bronchial smooth muscle, increase vascular permeability and 
contribute to AHR. There is an association between eosinophil activation and asthma 
severity, as well as AHR (Bousquet et al., 2000). In addition, eosinophils may 
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involve in the process of tissue modeling and fibrosis by the release of growth factors, 
elastase and metalloproteases (Bousquet et al, 2000). 
1.5,1.3.5 Epithelial cells 
Epithelial cells may also contribute to the inflammatory process in asthma. 
Epithelial cells produce a wide range of mediators, such as endothelins, eicosanoids, 
nitric oxide, growth factors, proinflammatory cytokines, chemokines，extracellular 
matrix proteins, and metalloproteases (Barnes, 1996; Bousquet et al., 2000). These 
mediators can induce bronchial obstruction, inflammation, as well as airway 
remodeling. In chronic asthma, bronchial epithelium is partly shed. The epithelium 
damage has been shown to contribute to AHR (Barnes, 2002; Raebum and Webber, 
1994). There may be a protective role of the epithelium in reducing AHR. The 
increase in AHR to stimuli may be due to the loss of a diffusion barrier, the loss of 
epithelial-derived relaxant factors and the loss of enzymes (such as neutral 
endoproteases) which are responsible for degrading the inflammatory mediators 
(Bousquet et al, 2000; Raebum and Webber, 1994). 
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1.5.1.4 Cytokines in asthma 
1.5.1.4.1 Inflammatory cytokines 
1.5.1.4.1.1 Interleukin-4 
IL-4 is the main cytokine involved in the pathogenesis of allergic diseases. IL-4 
induces differentiation of Th2 cell and IL-5, as well as synthesis of IgE by B cells 
(Chung and Barnes, 1999). Besides, it induces the expression of adhesion molecule 
(VCAM-1) on endothelial cells. Upregulation of this adhesion molecule enhances the 
adhesion of blood cells on the endothelium, hence promoting recruitment of T cells, 
eosinophils and monocytes into the airways. Moreover, IL-4 stimulates the mucus 
producing cells and fibroblast, and may be involved in pathogenesis of airway 
remodeling (Kips, 2001). Increased in levels of IL-4 mRNA and protein were found 
in the airway mucosa of asthmatics (Ying et al., 1997). The role of IL-4 has been 
demonstrated in IL-4 knock out mice model. Sensitization and exposure to 
ovalbumin in IL-4 deficient mice did not induce eosinophil infiltration, IgE 
production and increase in AHR (Bmsselle et al., 1994, 1995). IL-4 is shown to be 
essential in the induction of Th2 response and airway inflammation (Coyle et al., 
1995). 
1.5,L4,L2 Interleukin-5 
IL-5 is a primary cytokine involved in the development of eosinophilia in vivo. 
It is involved in eosinophil production, maturation, chemoattraction and activation in 
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asthma (Chung and Barnes, 1999). IL-5 may also be involved in AHR. The role of 
IL-5 in asthma has been demonstrated by the use of anti-IL-5 in asthmatic patients, 
which was shown to deplete the circulating eosinophils and prevents eosinophil 
recruitment into the airway after allergen challenge (Leckie et al., 2000). Moreover, 
studies with IL-5 deficient mice showed that both ovalbumin-induced eosinophilia 
and AHR was abolished in these animals (Foster et a!., 1996). 
1.5.1.4.1.3 Interleukin-6 
IL-6 is a pleiotropic cytokine secreted by a wide range of cells, particularly, 
monocytes/macrophages, T cells, B cells, and fibroblasts. IL-6 has growth regulatory 
effects on many cells, and is involved in T cell activation, growth and differentiation 
(Chung and Barnes, 1999). Besides, it induces terminal differentiation of B cells and 
secretion of immunoglobulin. It also acts as a cofactor that enhances IL-4 dependent 
IgE synthesis from B cells and may have a role in Th2-type responses. IL-6 may be 
involved in pathogenesis of asthma. There is increased release of IL-6 from alveolar 
macrophages in asthmatic patients after allergen challenge (Gosset et aL, 1991), and 
increased basal release compared with non-asthmatic subjects (Broide et al； 1992). 
The role of IL-6 in asthma, however, remains unclear. 
1.5.1.4.1.4 Granulocyte Monocyte Colony Stimulating Factor (GM-CSF) 
GM-CSF is a pleiotropic cytokine that regulates the proliferation, differentiation 
and function of haematopoietic cells. GM-CSF can be produced by macrophages, 
eosinophils, T cells, fibroblast, endothelial cells, airway smooth muscle cells and 
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epithelial cells. GM-CSF and IL-8 were shown to be involved in eosinophil 
chemoattraction and activation in vivo, and may participate in the etiology of AHR in 
mild asthma (Davies et al, 1997). In addition, GM-CSF was shown to regulate 
eosinophil functions in vitro. It promotes the survival of eosinophils (Hallsworth et 
al,’ 1992) and enhances the superoxide and L T C 4 production by eosinophils in vitro 
(Silberstein et al,, 1986; Soloperto et cd., 1991). Increased GM-CSF expression is 
observed in the bronchial epithelium of asthmatic patients (Sousa et cd” 1993)，and in 
T lymphocytes and eosinophils after allergen challenge (Broide and Firestein，1991). 
1.5.1.4.1.5 Tumor Necrosis Factor-a (TNF-a) 
TNF-a is produced by many cells including macrophages, T cells, mast cells, 
and epithelial cells, but the major source is macrophages. TNF-a being a 
proinflammatory cytokine exerts various effects that are related to asthma. TNF-a 
stimulates epithelial cells to release cytokines such as RANTES, IL-8 and GM-CSF. 
It also induces the expression of adhesion molecule ICAM-1 (Tosi et al, 1992), and 
enhances the IL-4-induced expression of VCAM-1 on endothelial cells (Thomhill et 
cd.’ 1991). This would increase the adhesion and migration of leukocytes into lung 
tissue. TNF-a was shown to induce the recruitment of neutrophils and eosinophils 
during airway inflammation (Lukacs et al” 1995). There is an increased expression 
of TNF-a mRNA in the airways of asthmatic subjects (Ying et al, 1991) and 
increased release of this cytokine from BAL cells of asthmatics (Cembrzynska-
Nowak et al.’ 1993). 
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L5.1.4.2 Anti-inflammatory cytokines 
1.5.1.4.2.1 Interleukin-lO 
IL-10, also known as cytokine synthesis inhibitor factor, is produced by T cells, 
monocytes/macrophage, B cells, mast cells and eosinophils. IL-10 is a potent 
anti-inflammatory cytokine that suppresses the synthesis of many cytokines that are 
upregulated in asthma. It suppresses the production of TNF-a, IL-lp，IL-6, MlP- la 
and IL-8 by monocytes/macrophages, IL-4 and IL-5 production by Th2 cells, and 
IL-8 and RANTES production from stimulated airway smooth muscle cells (Chung 
and Barnes，1999; Koulis and Robinson, 2000). It also inhibits the synthesis of 
superoxide anions and NO by activated monocytes/macrophages. Moreover, it 
inhibits survival of eosinophil (Takanaski et al” 1994) and reduces production of 
chemokines involved in eosinophil recruitment (Pretolani et al” 1999). In animal 
models, IL-10 is shown to be effective in suppressing the infiltration of inflammatory 
cells into airways (Zuany-Amorim et al, 1995; Woolley et al, 1994). IL-10 may 
have beneficial effects in asthma. There is a reduced expression of IL-10 mRNA and 
protein in alveolar macrophages from asthmatic patients (Borish et al., 1996). 
L5J.4.2.2 Interferon-/(IFN-j^ 
IFN-y is produced only by CD4+ and CD8+ T cells and natural killer cells. 
IFN-y produced from Thl cells exerts inhibition on Th2 cells. The effects of IFN-y 
have been demonstrated in various studies. Administration of exogenous IFN-y 
prevents the eosinophil infiltration and AHR in mice after allergen exposure 
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(Iwamoto et al., 1993). In asthmatic patients, nebulized IFN-y can reduce the number 
of eosinophils in BAL fluid (Boguniewicz et al.’ 1997). This suggests that IFN-y may 
have a therapeutic effect in asthma. Indeed, insufficient IFN-y production may be 
related to asthma (Halonen and Martinez, 1997). Reduced production of IFN-y by T 
cells is observed in asthmatic patients and this is associated with the disease severity 
(Leonard et al” 1997). 
L5.2 Airway hyperresponsiveness (AHR) 
AHR refers to an increased ability of the airways to narrow in response to a 
variety of bronchoconstrictor stimuli. It is one of the characteristic features of asthma 
and the degree of AHR correlates with the severity of asthma (0'Byrne and Inman, 
2003). Although the mechanism of AHR is unclear, it is thought to result from airway 
inflammation (Figure 1-1). Eosinophils can produce many changes in tissue that may 
lead to AHR. As mentioned, epithelial damage by activated eosinophils results in a 
loss of barrier function that exposes the sensory nerves and increases mucosal 
permeability to extrinsic irritants (Makino et al, 2000b). This enhances the 
stimulation of sensory nerves by inflammatory mediators to release neuropeptides 
including substance P, neurokinin A and calcitonin gene-related peptides. This would 
increase smooth muscle contraction. Moreover, eosinophils can contribute to AHR 
by the release of cysteinyl leukotrienes that cause bronchoconstriction, increased 
vascular permeability and exudation of plasma which result in thickening of the 
airway wall (Trivedi and Lloyd, 2007). In patients with chronic asthma, airway 
'remodeling' can be important factor contributing to the persistent AHR (Cockcroft 
18 
Chapter 1 
and Davis, 2006). Airway remodeling refers to the secondary structural airway 
changes that develop due to the chronic or prolonged effects of airway inflammation. 
The chronic inflammation causes increase in airway smooth muscle mass, exudation 
of plasma that causes edema, inflammatory cell infiltration and connective tissue 
deposition, all of which can cause airway wall thickening (Elias et al, 1999). 
Thickening of airway wall enhances the airway narrowing contributed by smooth 
muscle stimulation, hence promoting AHR. Increased contractility of airway smooth 
muscle, thickening of the airway wall and reduced airway caliber resulting from 
airway remodeling can all contribute to the persistent AHR. The increase in AHR 
caused by acute inflammation is transient and usually reversible. However, the 
increase in AHR which occurs as a result of airway remodeling is rather irreversible. 
Although the process of airway remodeling is gradual, it is an important factor that 
aggravates AHR in chronic asthmatics. 
1.5.3 Airway remodeling 
Asthma is recognized as a chronic inflammatory disorder which is associated 
with reversible airflow obstruction. However, in some patients the obstruction is not 
completely reversible even after aggressive treatment with anti-inflammatory and 
bronchodilator drugs (Djukanovic, 2000). The airway inflammation in asthma is also 
known to produce tissue injury and subsequent structural changes as a result of the 
regeneration and repair processes in the lung (Trivedi and Lloyd, 2007). These 
changes, which are collectively referred to as airway remodeling, may contribute to 
AHR and irreversible airflow obstruction, and also contribute to an increased rate of 
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decline of lung function over time (Trivedi and Lloyd, 2007; Djukanovic, 2000). A 
typical feature of airway remodeling is increased deposition of extracellular matrix 
(ECM) proteins such as fibronectin and collagens type I, III，and V within the 
reticular basement membrane (ie, the lamina reticularis) (Elias et al., 1999; Homer 
and Elias, 2005). The thickening of this layer is called subepithelial fibrosis. 
Myofibroblasts situated under the epithelium are the major producers of ECM 
proteins and are likely to contribute to the subepithelial fibrosis. Their numbers are 
increased in tissues during the repair process and correlate with the extent of collagen 
deposition (Brewster et al” 1990). Other prominent features of airway remodeling 
include an overall increase in airway wall thickness, smooth muscle hyperplasia and 
hypertrophy, epithelial hypertrophy, goblet cell hyperplasia and mucus 
hypersecretion. 
A large number of mediators have been proposed to contribute to airway 
remodeling (Homer and Elias, 2005; Trivedi and Lloyd, 2007). One of the most 
potent mediators of tissue fibrosis is transforming growth factor (TGF)-P (Figure 
1-1). TGF-p can stimulate fibroblast and smooth muscle proliferation and enhances 
ECM protein production. Other fibrogenic factors, including endothelin-1, 
platelet-derived growth factor and matrix metalloproteinase (MMP)-9 are also shown 
to contribute to airway remodeling. 
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1.6 Asthma therapy 
There are several different types of asthma medications. Their functions in 
asthma treatment are discussed below. 
1.6.1 P2-agonists 
P 2 - a g o n i s t s are effective and rapidly acting bronchodilators. They bind to and 
stimulate the p 2 - a d r e n o c e p t o r and increase the cyclic AMP, resulting in airway 
smooth muscle relaxation (Barnes, 2002; Shepherd et al, 2002). Despite this, 
P 2 - a g o n i s t s have no effect on the underlying inflammation that associated with 
asthma. Therefore, they should not used alone for the long-term control of asthma 
symptoms. p 2 - a g o n i s t s are available in two forms. The short-acting p 2 - a g o n i s t s (e.g. 
albuterol) are used to provide an immediate relief of acute asthma symptoms. The 
long-acting p 2 - a g o n i s t s (e.g. formoterol and salmeterol) have a longer duration of 
actions and are effective for at least 12 hours. They are used in combination with 
anti-inflammatory agents to control the asthma symptoms, particularly the nocturnal 
symptoms. 
1.6.2 Cromolyn and nedocromil 
Cromolyn sodium and nedocromil sodium are structurally different compounds 
but have similar anti-inflammatory properties. They have been shown to inhibit the 
release of mediators from mast cells and block both the early and late responses to 
allergen challenge (Shepherd et al, 2002). These drugs work by affecting the 
21 
Chapter 1 
functions of airway chloride channels. The use of these drugs, rather than the inhaled 
corticosteroid, may be sufficient to treat patients with mild asthma. 
1.6.3 Theophylline 
Theophylline, a methylxanthine, is a medication which provides 
bronchodilation by inhibiting phosphodiesterase (Shepherd et al, 2002). They may 
also have mild anti-inflammatory effects. They can be used as an add-on therapy to 
low or high doses of inhaled corticosteroids to gain control of asthma. However, they 
are considered to be less effective than the long-acting P 2 - a g o n i s t s in this regard. 
1.6.4 Leukotriene modifiers 
Leukotrienes are potent inflammatory mediators involved in the pathogenesis of 
asthma. They can cause brochoconstriction, edema, increased in vascular 
permeability and enhance mucus production. They are produced from the 
metabolism of arachidonic acid via the 5-lipoxygenase (5-LO) pathway. There are 
two major categories of leukotriene modifiers. The first one inhibits the production 
of leukotrienes by inhibiting the enzymes in the biosynthetic pathway (e.g. zileuton, 
the 5-LO inhibitor). The second class is leukotriene receptor antagonists (e.g. 
zafirlukast and montelukast), which act by blocking the action of leukotrienes. These 
drugs can produce a better overall control of asthma when used in conjunction with 




Corticosteroids, primarily inhaled corticosteroids, are the most effective 
anti-inflammatory agents currently available for the treatment of asthma. Treatment 
with inhaled corticosteroids has been shown to improve lung function and reduce the 
symptoms of asthma and AHR (Philips et al., 1999). They exert anti-inflammatory 
actions through a variety of mechanisms. They can decrease the number and 
activation of various inflammatory cells in the airways, including eosinophils, T 
lymphocytes, macrophages, dendritic cells and mast cells (Barnes, 2002). 
Furthermore, they can inhibit the release of numerous proinflammatory mediators 
and cytokines from these cells. Besides the suppressive effects on inflammatory cells, 
corticosteroids can inhibit microvascular leakage and mucus secretion (Lemanske 
and Busse, 2003). They produce their effect on various cells by binding to the 
cytoplasmic glucocorticoid receptors, which then modulate the transcription of 
certain target genes, such as cytokines and chemokines. 
23 
Chapter 1 
1.7 Traditional Chinese Medicine 
1.7.1 Introduction 
The current treatments for asthma are not satisfactory, and the use of systemic 
corticosteroids can be associated with some serious side effects including skin 
thinning, bruising, adrenal suppression, decreased bone metabolism and growth 
retardation which is of particular concern in children (Li et al., 2004). They also 
produce overall immune suppression, resulting in increased susceptibility to 
infections. Inhaled steroid has much less side effects however prolonged use may 
still cause concern. There is a need to search for better and safer therapeutics for 
asthma. The use of complementary and alternative medicines (CAM) for asthma has 
becoming more popular in the past 10 years, especially in the Western countries, and 
a growing number of asthmatic patients wish to try some forms of CAM (Graham 
and Blaiss，2000). CAM encompasses a wide range of therapies outside the domain 
of orthodox medicine. Patients with asthma choose to use CAM due to dissatisfaction 
with the treatment outcomes and/or side effects of conventional therapies. Herbal 
medicine has been one of the most popular choices of asthmatic patients. 
1.7.2 Traditional Chinese Medicine (TCM) 
TCM has a long history of use in China. It has been used by Chinese 
practitioners to treat asthma for centuries, and it is observed to have certain degree of 
clinical efficacy. TCM has become attractive as a source of alternative medicine. 
However, there is a lack of adequate scientific evidence for TCM. Some clinical 
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trials on Chinese medicines for asthma did show positive outcomes, but definitive 
evidence for TCM is rare due to the low quality of the trials (Huntley and Ernst, 
2000). Previously, Hsieh et al (1996) studied the efficacy of three Chinese herbal 
medicines in a clinical trial. Improvement of all the clinical parameters (symptom 
and medication scores, and peak expiratory flow) was observed after six months of 
treatment, although there was no significant difference when compared with patients 
in the placebo groups. In addition, there was a decrease in histamine release and 
enhanced production of PGE2 in vitro after treatment. In vivo studies were also 
performed in guinea pigs. They showed that pretreatment with the herbal medicines 
suppressed BALF eosinophilia and eosinophil infiltration of the airways, decreased 
LTC4 production and enhanced PGE2 production. Hsieh concluded that the Chinese 
herbal medicines showed some degree of efficacy in asthma treatment, although 
there was significant placebo effect present. Besides, there are other animal studies 
showing the therapeutic effects of Chinese medicines. Xiao-qing-long-tang is a TCM 
which has been used to treat bronchial asthma for centuries in China. It was shown to 
suppress the airway inflammation by decreasing the number of total cells and 
eosinophil infiltration in the BALF in allergen-challenged mice (Kao et al., 2000). 
Another classic Chinese herbal remedy used for asthma, Ding-Chuan-Tang, was 
shown to inhibit the ovalbumin-induced bronchoconstriction and airway eosinophil 
infiltration in sensitized guinea pigs (Kao et al, 2004). Table 1-1 summarizes the 
results of these studies. In summary, these studies suggest a potential of TCM in 
treatment of asthma. However, more research is needed to ascertain the effectiveness 
of TCM and its mechanisms of action. 
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1.7.i Chinese herbal formula，CU Formula 2 (CUF2) and Kuan Dong Hua 
According to the theory of TCM, there is a link between asthma and 'deficiency 
of the kidneys'. Recently, a novel Chinese herbal formula, CUF2, has been 
developed by Institute of Chinese medicine, Chinese University of Hong Kong based 
on the principles of TCM with the goal to relieve wheezing and reduce the frequency 
of attacks in asthmatic patients. The formula consists of five herbs，namely Radix 
astragali (Huang Qi)，Radix stemonae (Bai Bu)，Chuan Bei (Bulbus fritillariae 
cirrhosae), Dong Chong Xia Cao (Cordyceps sinensis) and Huang Qin (Radix 
Scutellariae). Figure 1-2 shows the crude component herbs of CUF2. These herbs 
have various pharmacological actions. Radix astragali has immunomodulatory, 
antioxidant and antirhinoviral activity (Huang, 1999). Radix stemonae and its 
alkaloids can suppress excitation of the respiratory center and inhibit the coughing 
reflex (Huang, 1999). Bulbus fritillariae cirrhosae can relieve cough, provide 
bronchodilation and inhibit mucosal secretions (Huang, 1999). Cordyceps sinensis 
has immunomodulatory activity and it can cause smooth muscle relaxation (Kuo et 
al.，2001; Huang, 1999). Radix Scutellariae exhibits antimicrobial, anti-inflammatory 
and sedative functions, and is often used in bronchitis and chronic obstructive airway 
disease (Huang, 1999). In vitro study showed that CUF2 suppressed the release of 
eosinophil cationic protein from eosinophils and reduced the production of TNF-a 
and gene expression of IL-2 receptor on PBMC (Lee et cd., 2006). In addition, it was 
shown to be effective in reducing inflammatory responses, and have 
immunomodulatory effects on the Thl/Th2 responses in a well-characterized rat 
model of asthma (Wong et al, 2006). CUF2 was further shown to have a certain 
degree of efficacy in a multi-center, randomized, double blind, placebo controlled 
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clinical trial. These findings suggest that CUF2 may have beneficial effect in the 
treatment of asthma. However, limited studies have shown that four of the five 
ingredients of CUF2 contributed to the beneficial effects. Therefore, the aim of this 
study is to clarify the therapeutic activity of the four individual ingredients of CUF2 
(Radix astragali, Radix stemonae, Bulbus fritillariae cirrhosae and Radix Scutellariae). 
The fifth ingredient Cordyceps sinensis was not studied because our preliminary 
study on this herb gave unsatisfactory results (unpublished data). 
Furthermore, another Chinese herb, Flos farfarae (Kuan Dong Hua) was also 
included in our studies. This herb has been used for treatment of asthma in China for 
centuries (The crude herb is shown in Figure 1-2). It was also used to treat chronic 
bronchitis, tuberculosis, and upper respiratory infections. It is an effective antitussive 
and expectorant agent (Huang, 1999). However, the scientific evidence for the 
efficacy of this herb is lacking. Recently, the extract of Kuan Dong Hua had been 
shown to have complementary anti-inflammatory effects in asthmatic patients in a 
clinical trial (Lee et al, 2004). It is therefore of interest to investigate the possible 
therapeutic effect of Kuan Dong Hua on asthma. This helps to provide a scientific 
basis of this herbal medicine in the treatment of asthma. 
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1.8 Objectives of our studies 
The aim of our studies was to investigate the therapeutic activity of the four 
individual ingredients (Huang Qi，Bai Bu, Chuan Bei and Huang Qin) of CUF2 and 
Kuan Dong Hua in a rat model of allergic asthma. There were three specific 
objectives of our studies: 
1. To establish an animal model of asthma using house dust mite in 
Sprague-Dawley (SD) rat (Chapter 2), 
2. To study the effect of each of the four individual component herbs (Huang Qi, 
Bai Bu, Chuan Bei and Huang Qin) of CUF2, and also Kuan Dong Hua on the 
airway inflammation, as well as their immunomodulatory effect on Thl/Th2 
responses in the established rat model of allergic asthma (Chapter 3). 
3. To study the immunomodulatory effect of Kuan Dong Hua on the cytokine 

























































































































































































































































































































































































































































































































































































































































































Figure 1-1. Cellular interactions in asthma. The interaction of allergen on IgE on 
mast cells leads to release of histamine and lipid mediators from mast cells, resulting 
in acute airway narrowing (bronchospasm). APC in the airways present allergen to 
the CD4 cells. IL-4 and IL-13 released by the Th2 CD4+ cells stimulate IgE 
production by B cells. IL-5 facilitates the development and activation of eosinophils. 
TGF-P, together with IL-4 and IL-13 have direct effects on fibroblasts {fib), 
epithelial cells {epi), and airway smooth muscle (ASM) that leads to the release of 
growth factors and fibrogenic factors involved in remodeling, AHR and airway 
narrowing. Eosinophils have a direct effect on airway narrowing through the release 
of basic proteins and lipid mediators and may contribute to airway remodeling 
through the release of TGF-p，IL-4 and IL-13. Abbreviations are found in the text. 
Figure adapted from Larche et al. (2003). 
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Figure 1-2. Illustration of the herb components of CUF2 ( A - E ) and Kuan Dong 





ESTABLISHMENT OF A HDM-INDUCED ASTHMATIC 
ANIMAL MODEL IN SD RATS 
2.1 Introduction 
Animal models are valuable tools for understanding the pathophysiology of 
asthma and development of new drugs for asthma. Today, animal models of asthma 
have been established mainly by using ovalbumin which is not a common allergen 
involved in human asthma (Tournoy et al, 2000). It is important to develop animal 
models using clinically relevant allergens. HDM is the most common allergen in 
human asthma and exposure to HDM is an important cause of asthma (Sporik et al； 
1992). Therefore, HDM model is more valuable in the study of asthma, though it is 
more expensive than ovalbumin model. Rats have been extensively used to model 
asthma. Most characteristic features of human asthma can be duplicated in rats 
(Szelenyi, 2000). The purpose of this study is to establish an animal model of asthma 
induced by HDM in Sprague-Dawley (SD) rats. Although SD rat had been shown to 
develop less robust response to HDM than the Brown Norway rat (BN) which is the 
most suitable choice of rat strain (Singh et al,, 2003), SD rats are much cheaper and 
more readily available than BN rats. We hypothesized that an asthma animal model 
could also be developed with SD rats using HDM. 
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2.2 Materials and methods 
2.2.1 Buffers and solutions 
Normal saline was prepared by dissolving 0.9% (w/v) NaCl in distilled water and 
autoclaving to sterilize. 
1 X Phosphate Buffered Saline (PBS) was prepared by dissolving 8 g NaCl, 0.2 g 
KCl, 1.44 g Na2HP04 and 0.24 g KH2PO4 in 1 L distilled water. The pH was adjusted 
to 7.4 with 1 N HCl before sterilized by autoclaving. 
10 X Ammonium Chloride Lysing Solution was prepared by dissolving 8.29 g 
NH4CI, 1 g KHCO3 and 1 mM EDTA in 100 ml distilled water. The pH was adjusted 
to 7.2 -7.4 with 1 N HCl or 1 N NaOH and stored at 4°C. The working solution 
(0.83% w/v NH4CI) was prepared before use by diluting 1:10 with distilled water to 
make fresh lysing solution. 
10% Neutral Phosphate-Buffered Formalin (NBF) was prepared by combining 4 
g NaH2P04.H20 and 6.5 g Na2HP04 and 100 ml formaldehyde (37% solution) in 1 L 
distilled water. The pH was adjusted to 7.0 -7.2 with 5 N NaOH. 
2.2.2 Animals 
Specific pathogen free, male Sprague-Dawley rats (6 weeks old, 70-80 g), were 
obtained from Laboratory Animal Services Center of the Chinese University of Hong 
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saline to 1 mg/ml and stored in aliquots at -20°C until use. 
2.2.5 Sensitization Procedure 
A saline suspension containing 30 |ig/ml of HDM adsorbed to 10% (w/v) 
A1(0H)3 as adjuvant was freshly prepared before sensitization. Rats were actively 
sensitized by an intraperitoneal injection of 0.5 ml of HDM-A1(0H)3 suspension and 
an subcutaneous injection of 1.2 ml HDM-A1(0H)3 suspension at the neck (bilateral), 
back, loin, groin and abdomen (0.2 ml at each point) on Days 1 and 3. Naive group 
animals served as normal controls, sham sensitization was done with normal saline 
using the same procedures. 
2.2.6 Intratracheal instillation challenge 
Rats were challenged with HDM by intratracheal instillation on each of days 18， 
24 and 30. For tracheal instillation, rats were anesthetized by intraperitoneal injection 
of a cocktail of ketamine (37.5 mg/kg) and xylazine (7.5 mg/kg) (both from Alfasan, 
Woerden, Holland) and then intubated by the method described by Foster et al. 
(2001). The rats were suspended by their upper incisors from a rubber band on a 
slanted platform, as shown in Figure 2-1. The trachea was transilluminated to allow 
visualization of the trachea through the oral cavity. With the mouth kept open and the 
tongue held out, a 16-gauge angiocatheter (BD Biosciences, 50 mm in length; 
internal diameter, 1.7 mm) was gently inserted through the vocal cords into the 
trachea. After confirming that the rat was breathing through the catheter, 50 |ag of 
HDM in 100 |al of sterile saline was instilled into the catheter with a pipet. The rats 
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Kong. They were housed in the animal facility at the Prince of Wales Hospital, which 
was maintained at 22°C, 50% relative humidity, with an automatic 12-h light/dark 
cycle. Rodent chow (PMI Nutrition International, Richmond, IN) and water were 
available ad libitum. All experimental protocols were approved by the Animal 
Experimentation Ethics Committee of the Chinese University of Hong Kong. 
2.2.3 Preparation of aluminum hydroxide gel 
Aluminium hydroxide gel was prepared according to the formula as below: 
AICI3 + 3 NaOH — A1(0H)3 “ 3 NaCl 
6.84 g AICI3 (Merck, Darmstadt, Germany) and 6.16 g NaOH (Sigma Chemical 
Co., St. Louis, MO, USA) were dissolved in 30 ml deionized water, respectively, 
then the NaOH solution was added into AICI3 solution. The mixture was stirred for 
40 min and a white precipitate of aluminium hydroxide was formed, which was 
collected by suction filtration in a filter funnel. The gel was leached repeatedly with 
deionized water during filtration. About 6 g of A1(0H)3 was obtained finally. 
2.2.4 HDM Allergen 
Semipurified HDM antigen derived from Dermatophagoides farinae was 
purchased from Greer Laboratories (Lenoir, NC，USA). The group I allergen {Der/I) 
was purified to >75% as determined by the vendor using a combination of 
ammonium sulfate precipitation, diethylaminoethyl (DEAE) ion-exchange 
chromatography, and gel filtration. The antigen was rehydrated in sterile isotonic 
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were then held in upright position for 1 min for liquid to be inhaled into the lungs by 
normal breathing. Control animals underwent the same procedures except that saline 
was instilled instead of HDM. 
2.2.7 Bronchoalveolar lavage (BAL) and BAL Cell counting 
Twenty-four hours after the last HDM challenge, the rats were killed by 
intraperitoneal injection of an overdose of ketamine and xylazine and the thoracic 
cavity was opened. BAL was performed as previously described by Foster et al. 
(Figure 2-2). The trachea was exposed surgically, and a blunt plastic cannula was 
inserted and tied to the trachea. The left lung was tied off at the main stem bronchus 
with a silk thread suture to prepare for histopathological study. The right lung lobes 
were lavaged three times with a single 6.0 ml volume of ice-cold PBS. The recovered 
volume was consistently greater than 75% of the instilled volume. The collected 
bronchoalveolar lavage fluid (BALF) was immediately cooled at 4°C and centrifuged 
at 1,500 rpm for 10 min. The supernatant was frozen at -80°C for subsequent 
cytokine analysis. The BALF cell pellet was incubated with 1 ml of 0.83% 
ammonium chloride lysing solution at room temperature for 7 min to remove the 
contaminating red blood cells. The cell pellet was then washed once with PBS and 
then resuspended in 1 ml IMDM containing 10% FBS. The total number of cells (per 
ml total BALF recovered) was determined with a standard hemacytometer 
(Reichert-Jung，Cambridge Instruments Inc., Buffalo, NY, USA). Cytospin 
preparations were made by centrifugation of 100 \x\ aliquots containing 5 x lo"^  cells 
(spun at 500 rpm for 5 min) onto glass slides in a Cytospin (Model 2, Shandon Ltd., 
Runcorn, UK). Differential BAL cell count was performed by staining with a 
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modified Wright-Giemsa stain (The protocol is shown in Appendix A). Stained 
slides were examined using light microscope (xlOOO magnification, under oil 
immersion). At least 200 cells were counted and identified as macrophages, 
eosinophils, lymphocytes, or polymorphonuclear cells using standard morphological 
criteria. All samples were evaluated in a blind manner. The proportion of each cell 
type was multiplied by the total cell count to determine each respective cell count. 
2.2.8 Lung HistopathologicalAnalysis 
After BAL sampling had been performed, the left lung lobe was removed from 
the thoracic cavity by careful dissection and fixed immediately with 10% (v/v) 
neutral phosphate-buffered formalin for 24 h. After fixation, the tissues were 
processed routinely through dehydration in graded alcohols, clearing in xylene, and 
finally embedded in paraffin blocks. 5-|im-thick serial sections were cut using a 
microtome (Finesse, Shandon) and transferred onto microscope slides. After paraffin 
removal and rehydration, the slides were stained with hematoxylin and eosin (H&E) 
to examine infiltrating cells, Congo Red for identification of eosinophils, and 
periodic acid-Schiff (PAS) for identification of mucus-containing cells (The protocol 
of the staining is shown in Appendix B-D). 
H&E stained sections were examined under light microscopy for evaluation of 
the severity of inflammation as previously described (Toumoy et al., 2000). Sections 
were coded and graded in a blinded fashion using a semiquantitative scoring system 
(0- 3). A score of 0 was given for no inflammation, a score of 1 for minimal or 
occasional inflammatory cells scattered through the lung, a score of 3 for abundant 
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inflammatory cells scattered through the lung, and a score of 2 for inflammatory cells 
between the levels of 1 and 3. Four tissue sections per animal were scored, and 
inflammation scores were expressed as a mean value and could be compared 
between groups. 
The number of peribronchial eosinophils of lung tissue was quantified under 
light microscopy using a method previously described by Lundy et al. (2005) with a 
slight modification. Eosinophils were clearly identified by their Congo Red stained 
positive granules in the cytoplasm and were counted in 4 random high-power fields 
adjacent to large airways at 400 X magnification. Four tissue sections were counted 
for each rat (6-7 rats per group). Results were expressed as the number of eosinophils 
per high-power-field (HPF) of lung tissue. 
Examination of goblet cell hyperplasia was carried out using a method 
previously described by Lima et al (2005). Goblet cells were mostly found in the 
large airways after multiple antigen challenges. The number of total epithelial cells 
and PAS-positive goblet cells (stained purple/magenta) in the epithelium of large 
airways was counted using light microscopy at a magnification of x 400. The 
abundance of goblet cells within the airway epithelium was scored in a blinded 
fashion using a 5-point grading (0 - 4) system: 0 < 5 % goblet cells; 1 = 5-25%; 2 = 
25-50%, 3 = 50-75%, 4 > 75%. The sum of the airway scores from each lung was 
divided by the number of airways observed (8-10 per rat) to determine the 
histological goblet cell score (expressed as arbitrary units; U). 
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2.2.9 Measurement of cytokine and chemokine by Enzyme-Linked Immunosorbent 
Assay (ELISA) 
The concentrations of rat IL-4, IL-6, IL-10, IFN-y, TNF-a, and MCP-1 in the 
BALF supematants were measured by sandwich ELISA using commercially 
available Pharmingen's OptEIA kits (San Diego, CA, USA) according to the 
manufacturer's instructions. In these assays, 96-well ELISA plates (Maxisorp; Nunc, 
Roskilde, Denmark) were coated with 100 [il/well of capture antibody in coating 
buffer overnight at 4°C. The next day, wells were washed with wash buffer (PBS 
with 0.05% (v/v) Tween-20) and incubated with 200 |al/well of assay diluent (10% 
FBS in pH 7 PBS) for 1 h at room temperature to block nonspecific protein binding 
sites. After washing with wash buffer, 100 |il of recombinant standards or sample 
dilutions were added to appropriate wells and incubated for 2 h at room temperature. 
Plates were washed with wash buffer, and incubated with 100 |il/well of detection 
antibody for 1 h and 100 |al/well of enzyme reagent for 30 min (or a 100 |al/well of 
detection antibody and enzyme reagent mixture for 1 h) at room temperature. 
Unbound detection antibody and enzyme were removed by seven consecutive 
washings. Finally, the color was developed using a mixture (100 |j.l/well) of 
3,3',5,5'-tetramethylbenzidine (TMB) chromogen and hydrogen peroxide (H2O2) 
substrate. After incubation at room temperature for 30 min in the dark, 50 |al/well of 
stop solution (1 M H3PO4) was added to stop the reaction. Absorbance was measured 
at 450 nm with a microplate reader (|iQuant; Bio-tek Instruments, Winooski, VT) 
within 30 min of stopping reaction. The results are expressed as picograms per 
milliliter (pg/ml) based on calibration curves constructed using recombinant 
cytokines as standards in each assay. Each sample was assayed in duplicate. The 
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detection limits were 1.6 pg/ml for IL-4, 78 pg/ml for IL-6, 15.6 pg/ml for IL-10, 
31.3 pg/ml for IFN-y, MCP-1 and TNF-a. No detectable cross-reactivity with other 
cytokines has been reported for the ELISA kits used. 
2.2.10 Statistical Analysis 
The data were expressed as mean 士 standard error of the mean (S.E.M.). 
Between-group differences were analyzed by Student's two-tailed Mest. To compare 
the pathological grade of each group, the Mann-Whitney test, a non-parametric 
method, was used. All statistical analyses were performed using Graphpad Prism 
v.4.0 (GraphPad Software, San Diego, CA，USA). Results of 户<0.05 were 




2.3.1 Cellular Analysis of BALF 
We studied the effect of HDM {Der 力-induced lung inflammation in SD rats as 
measured by the BAL cell numbers. In the saline sensitized and challenged rats, the 
total cell number in BALF was 5.6 ± 1.1 x lOVml. HDM sensitization and challenges 
significantly augmented the total cell numbers to 37.9 士 3.0 x 10'^ /ml 24 h after the 
final antigen challenge (Figure 2-3 A，PO.OOl). 
The majority of BAL cells in the saline-challenged group were macrophages 
(96.4 土 1.1%) (Figure 2-3B and 2-4A). Few neutrophils and lymphocytes were 
detected (2.0 土 0.8o/o and 1.5 土 0.4o/o respectively), and eosinophils were virtually 
absent (0.1 士 0.1%). HDM challenges significantly increased the proportions of 
neutrophils, lymphocytes and eosinophils to 51.4 士 2.2o/o (P<0.001), 6.0 土 1.2o/o 
( P < 0 . 0 1 ) and 11.6 土 1 . 2 % (户 < 0 . 0 0 1 ) respectively, with a significant decrease in the 
proportion of macrophages to 30.9 土 2.3o/o (PO.OOl) (Figure 2-3B). The change in 
cellular composition of BALF after HDM challenges was illustrated in the cytospin 
preparations shown in Figure 2-4. 
The absolute numbers of each cell type were shown in Figure 2-3C. Following 
HDM challenges, there was a marked and significant increase in the absolute number 
of macrophages (11.8 ± 1.3 vs 5.5 士 1.1 x l o V l , P<0.01), neutrophils (19.6 士 1.7 vs 
0.1 土 0.0 X 104/ml，PcO.OOl)，lymphocytes (2.2 士 0.3 vs 0.1 土 0.0 x loVl,尸<0.001) 




The HDM-induced lung inflammation in SD rats was also investigated by 
histological examination of the rat lungs 24 h after the final challenge. Histological 
analysis of repeatedly HDM challenged rats showed massive infiltration of 
lymphocytes around the airways and blood vessels (Figure 2-5B). In contrast, saline 
challenged rats showed normal lung histology with no inflammatory signs (Figure 
2-5A). An increase in inflammation score was observed in the lungs of HDM 
challenged rats compared with naive rats (2.8 土 0.2 vs 0.3 士 0.2，P<0.01) (Figure 
2-8A). Moreover, eosinophils in the pulmonary tissue were identified by staining 
with Congo Red. Nearly no eosinophils were found in the lung sections of saline 
challenged rats. After HDM challenges, prominent eosinophilic infiltration was 
observed in the peribronchial and perivascular tissues (Figure 2-6). Morphometric 
analysis of peribronchial eosinophils was performed. There was a significant increase 
in the number of eosinophils around the airways following HDM challenges (90.9 士 
10.7 vs 3.8 士 0.9 /HPF, PO.OOl) (Figure 2-8B). In addition, goblet cells in the tissue 
were identified by the PAS method. HDM challenges induced a marked proliferation 
of goblet cells in the airway epithelium of rats (Figure 2-7). The goblet cell score 
(ratio of goblet cells/epithelial cells) of the large airways was significantly increased 
in the HDM challenged rats (1.5 士 0.1 vs 0.1 士 0.1，P<0.01)(Figure 2-8C). 
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2.3.3 Cytokine and chemokine 
The changes in cytokine and chemokine levels in BALF after HDM challenges 
were shown in Figure 2-9. Saline challenged rats had very low or undetectable levels 
of all the cytokines tested except MCP-1. HDM challenges significantly increased 
levels of IL-4 (5.0 土 0.7 vs 2.5 士 0.3 pg/ml，P<0.05), IFN-y (67.5 土 13.0 vs 13.0 土 
3.2 pg/ml, PO.Ol), IL-10 (78.2 土 12.3 vs 21.9 土 2.4 pg/ml, P<0.01), IL-6 (230.8 土 
36.4 vs 131.8 士 21.3 pg/ml, P<0.05), TNF-a (53.2 土 6.8 vs 0.0 pg/ml, P<0.01) and 




Animal models are useful tools for understanding the pathophysiology and 
treatment of asthma. Animal models of asthma have been developed mainly based on 
ovalbumin which is an uncommon allergen in asthma. It is important to develop 
asthma models using clinically relevant allergens. HDM is the most common 
allergen in asthma and sensitization to HDM is an important risk factor for the 
development of asthma (Toumoy et al, 2000). Therefore, HDM model would be 
most valuable for the study of asthma. HDM has been shown to induce asthma 
response in a variety of laboratory animals, including mice (Yu et al,, 1997 & 1999)， 
rats (Dong et al, 2003)，guinea pigs (Hsiue et al., 1997; Yasue et al, 1999) and 
monkeys (Van Scott et al” 2004; Schelegle et al, 2001). In this study, we aimed to 
develop an animal model of asthma using the clinically relevant allergen HDM in SD 
rats. 
We used a similar sensitization and challenge scheme as described in BN rats by 
Singh et al (2003). Since sensitization by systemic injection was shown to elicit 
better response, HDM was injected subcutaneously for allergen sensitizations on 
days 1 and 3 as described by Singh et al However, we have slightly modified the 
sensitization method by using a multiple point subcutaneous injection at various sites 
which are in proximity of lymph nodes and have also involved an additional i.p. 
administration of allergen to enhance immunization. Animal models of asthma are 
often developed by injection of allergen and adjuvant followed by repeated 
exposures to allergen. This has been shown to induce chronic inflammation in many 
studies. In this regard, the rats were challenged with HDM intratracheally three times 
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on days 18, 24 and 30 after sensitization. Similar to Singh's study, we used 
intratracheal instillation as antigen challenge method because it avoids contact of 
upper airways with allergens and can deliver larger amounts of allergens in a more 
consistent way than by the inhaled aerosol challenges (Blyth et al, 1998). This 
method may be able to induce more marked histologic changes in the model. For the 
tracheal intubation, we have tried different catheters and techniques and eventually 
obtained satisfactory results by using a 16-gauge angiocatheter without other 
instrumentation. 
In the present study, repeated HDM {Der f ) challenges induced a series of 
cellular and immunologic responses with characteristics of allergic inflammation. 
Asthma is characterized by infiltration of inflammatory cells, particularly eosinophils, 
into the airways (Rosenwasser, 2000). It is now known that airway inflammation 
contributes to the pathogenesis of asthma. We have shown that HDM challenges 
resulted in a significant increase in the total cell number in BALF in sensitized SD 
rats compared to the saline-treated animals. There was a significant increase in the 
number of eosinophils in BALF which constituted about 10% of BAL cells, although 
the numbers of lymphocytes, neutrophils and macrophages in the BALF were also 
significantly increased. The increase of neutrophils and macrophages was possibly 
due to the nonspecific irritative effects of the dust mite proteins (Hsiue et al., 1997). 
Furthermore, histological analysis of HDM sensitized and challenged rats showed 
that there was marked peribronchial and perivascular infiltration of lymphocytes and 
eosinophils in the lung tissue. An increase in the number of eosinophils in the 
airways is a hallmark of allergic asthma (Mould et al., 2000). In contrast, little cell 
infiltration was seen in the lungs of saline sensitized and challenged animals and 
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eosinophils were virtually absent in airways. We have shown that repeated challenges 
with HDM lead to recruitment of inflammatory cells including lymphocytes and 
eosinophils in the airways of the sensitized rats. 
Evidence shows that the inflammatory state in asthma is contributed by a 
network of cytokines and mediators (Yu et al., 1997). In this study, we showed that 
HDM-induced airway inflammation in SD rats was associated with a significant 
increase in the level of the Th2 cytokine, IL-4, and the proinflammatory cytokines, 
including IL-6 and TNF-a in the airways. IL-4 is an important cytokine in allergic 
asthma. IL-4 enhances IgE production from B cells and is important for inducing the 
polarized Th2 response (Chung and Barnes, 1999). There is an increased level of 
IL-4 in BALF of allergic asthmatics (Walker et al., 1992), and increased expression 
of IL-6 and TNF-a in the airways of asthmatics (Chung and Barnes, 1999). 
Furthermore, we observed that the ‘ anti-inflammatory' cytokines IL-10 and IFN-y 
were also significantly increased in BALF of HDM-treated rats compared to normal 
rats. Although IL-10 has been shown to exhibit anti-inflammatory actions, the role of 
IL-10 in asthma has not been fully clarified. Some studies have shown that this 
cytokine might contribute to the pathology of asthma by enhancing AHR and allergic 
inflammation (Encinas et al, 2005). An elevation of the Thl cytokine IFN-y 
following HDM challenge was probably caused by the local inflammatory response 
or activation of Thl cells (Yu et al” 1999). In fact, IFN-y has been identified in 
BALF of asthmatic patients and is considered as an important modulator of the 
disease process (Holtzman et al., 1996). 
In addition to these cytokines, the chemokine monocyte chemotactic protein-1 
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(MCP-1) was also significantly increased in the BALF from the HDM-treated rats. In 
asthmatic patients, there is an increase of MCP-1 in the airways which is produced 
by bronchial epithelial cells, macrophages, and smooth muscle cells. MCP-1 plays a 
key role in the induction of Th2 inflammatory response. It recruits Th2 cells into the 
airway and enhances the Th2 cell differentiation. It also induces remodeling of the 
airways by stimulating TGFpl release from macrophages and fibroblasts (Cohn et al, 
2004). 
Hypersecretion of mucus is one of the characteristic features of asthmatic 
airways both in humans and animal models (Matsuoka et al,, 2000). We next 
examined the effect of HDM challenge on the goblet cell number in the bronchial 
epithelium of the rats. We observed marked goblet cell hyperplasia in the large 
airways of HDM sensitized and challenged rats whereas few goblet cells were 
detected in the saline sensitized and challenged rats. Goblet cell hyperplasia has been 
established as a pathologic characteristic of bronchial asthma. Excessive secretion of 
mucus associated with goblet cell hyperplasia can contribute to the airway narrowing, 
and resulting in airflow obstruction. Mucus hypersecretion has been identified as a 
cause of morbidity and mortality in asthmatic patients (Fahy, 2002). 
The study by Singh et al (2003) has compared the airway response to HDM 
antigen in three rat strains. They showed that SD rats demonstrated only moderate 
response to HDM as compared with BN rats. We were unable to compare our 
histology results with their results because of limited data from their study. However, 
in contrast with Singh et al.,s study, we showed significant increase in total cells and 
eosinophils, as well as the Th2 cytokine in BALF, after HDM challenges in SD rats. 
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Basically, we used an antigen sensitization and challenge protocol similar to that 
employed in their study. The differences observed in both studies were possibly due 
to a higher sensitization and challenge dose of HDM we used. Besides, this may be 
due to a modification of the sensitization method used in our study. We have used a 
multi-point subcutaneous injection at various sites and included an additional i.p. 
administration which may enhance immunization to antigen. 
In conclusion, we have successfully established an improved animal model of 
allergic airway inflammation induced by HDM {Der f ) in SD rats. This unique rat 
model displayed many features of human allergic asthma, including pulmonary 
infiltration of inflammatory cells, increased recruitment of eosinophils in BALF and 
lung tissue, increased level of numerous cytokines and chemokine in BALF, as well 
as proliferation of goblet cells within the airways. We believed that this improved 
animal model should facilitate further studies of pathogenic mechanism and the 
potential therapeutic agents of asthma. 
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Figure 2-3. Cellular composition of BALF after HDM challenges. Rats were 
sensitized twice and exposed to 3 intratracheal instillations of HDM or saline (Naive) 
as described in Materials and Methods (Section 2.2.5-6). Total and differential cell 
counts of BALF were determined 24 h after the last challenge as described in 
Methods and Materials (Section 2.2.7). (A) Total cell number in BALF, (B) 
percentage and (C) absolute number of various infiltrating inflammatory cells in 
BALF. Results are expressed as mean 士 SEM (n = 8 for HDM group, n = 7 for naive 
group). “ 尸 < 0 . 0 1 ， 尸 < 0 . 0 0 1 compared with saline sensitized and challenged rats. 
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Figure 2-4. Representative micrographs of cytospin preparations of BALF at 24 h 
after (A) saline (naive) or (B) HDM challenges. Rats were sensitized twice and 
exposed to 3 intratracheal instillations of HDM or saline as described in Materials 
and Methods (Section 2.2.5-6). Cytospin preparations were made and stained with 
Wright Giemsa as described in Materials and Methods (Section 2.2.7). Arrows 
depicted individual cell types as determined by morphology. MO, macrophages, 








Figure 2-5. Histopathologic changes in HDM-challenged rats. Rats were sensitized 
twice and exposed to 3 intratracheal instillations of HDM or saline {naive) as 
described in Materials and Methods (Section 2.2.5-6). The lungs were prepared 24 h 
after the last pulmonary challenge. (A) Representative histology from naive rats with 
essentially normal histology. (B) Histology from HDM-challenged rats with a 
marked peribronchial and perivascular infiltrate of lymphocytes. H&E staining; 
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Figure 2-6. Histological analysis of lung sections stained with Congo Red. Rats were 
sensitized twice and exposed to 3 intratracheal instillations of HDM or saline (naive) 
as described in Materials and Methods (Section 2.2.5-6). The lungs were prepared 24 
h after the last pulmonary challenge. Naive rat showed almost no eosinophils in the 
airways (A). HDM sensitized and challenged rats showed massive peribronchial and 
perivascular eosinophilic infiltration (B-C). Arrows and inset indicate eosinophils. 
Magnification: A and B: x400; Inset: ><640，C: xl60. AL, airway lumen; BV, blood 










Figure 2-7. Histological analysis of lung sections stained with PAS for goblet cells. 
Rats were sensitized twice and exposed to 3 intratracheal instillations of HDM or 
saline {naive) as described in Materials and Methods (Section 2.2.5-6). The lungs 
were prepared 24 h after the last pulmonary challenge. Few goblet cells were 
detected in airways of naive rats (A and C). Goblet cell hyperplasia was seen in 
airways of HDM sensitized and challenged rats (B and D). Arrows indicate goblet 
cells within the respiratory epithelium. Magnification: A and B: x50; C and D: x400. 
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Figure 2-8. Effect of exposure to HDM or saline on (A) inflammation score, (B) 
lung eosinophil number and (C) goblet cell score. Rats were sensitized twice and 
exposed to 3 intratracheal instillations of HDM or saline {Naive). Inflammation 
scores, eosinophil numbers and goblet cell scores were evaluated as described in 
Methods and Materials. Results are expressed as mean 士 SEM of 6-7 rats per group. 




 ？  nh
uMJ
 
0 I  0  3  (
“ 























 w  15
0-
 H  M
s 











 -  I  I
,一
臺







 工  DM  M
ai
ve




































 ^  100
J 
「  NC  Ji
/务



























Figure 2-9. Effect of saline and HDM challenges on (A) IL-4, (B) IFN-y, (C) IL-10 
(D) IL-6, (E) TNF-a and (F) MCP-1 levels in BALF. Rats were sensitized twice and 
exposed to 3 intratracheal instillations of HDM or saline (Naive) as described in 
Materials and Methods (Section 2.2.5-6). Cytokine and chemokine concentrations 
were determined by ELISA. Samples were obtained 24 hours after the last challenge. 
Each value represents the mean 士 SEM of 6 to 8 rats. *P<0.05，**P<0.01，…尸<0.001 




IMMUNOMODULATORY EFFECT OF CUF2 AND 
KUAN DONG HUA IN A RAT MODEL OF 
HDM-INDUCED ASTHMA 
3.1 Introduction 
Asthma is a chronic inflammatory disease of the airways, the prevalence of 
which has increased dramatically in the recent decades. Asthma is characterized by 
airway inflammation, increased mucus production, intermittent airway obstruction 
and increase in AHR (Bousquet et al., 2000). The inflammatory response in asthma 
caused by allergen plays a central role in the pathogenesis of asthma. 
Anti-inflammatory therapy is the current established asthma treatment. Inhaled 
corticosteroids are the most effective anti-inflammatory medications currently 
available for the treatment of asthma. However, the long term use of corticosteroids 
is associated with serious side effects, such as growth retardation which is of 
particular concern in children (Li et al., 2004). Consequently, there is an increased 
need for the development of new or alternative therapies for asthma. Traditional 
Chinese medicine (TCM) has been used in the treatment of asthma in China for 
several centuries and showed some clinical efficacy in asthma patients (Hsieh et al” 
1996). TCM appears to be safe and effective alternative medicine for treating asthma. 
However, there is a lack of scientific evidence of TCM. Recently, we have 
demonstrated the beneficial effects of our innovative TCM antiasthma formula which 
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consists of five ingredients, known as CUF2, in in-vitro study (Lee et cd., 2006) and 
animal study (Wong et al； 2006). However, the efficacy of each of the ingredients in 
CUF2 and their mechanisms of action were unclear. The aim of this study was to 
evaluate the anti-inflammatory and immunomodulatory effect of each of the four 
ingredients in CUF2 [Radix astragali (Huang Qi), Radix stemonae (Bai Bu), Bulbus 
fritillariae cirrhosae (Chuan Bei) and Radix Scutellariae (Huang Qin)] in the 
established rat model of asthma induced by HDM. The fifth component Cordyceps 
sinensis (Dong Chong Cao) was not studied because our preliminary study on this 
herb gave unsatisfactory results. Instead, another herb Flos farfarae (Kuan Dong 
Hua), which has been reported to have anti-inflammatory effects in a clinical trial, 
was also examined on this in-vivo model. The effects of these herbs on the 
inflammatory cell infiltration in BALF and lung tissue, goblet cell hyperplasia, and 




3.2 Materials and methods 
3.2.1 Herbal materials and extraction method 
All herbs used in this study, Chuan Bei, Huang Qi, Huang Qin, Bai Bu, and 
Kuan Dong Hua were purchased from a herbal supplier in Hong Kong. Herbarium 
voucher specimens were deposited at the museum of the Institute of Chinese 
Medicine, the Chinese University of Hong Kong (Voucher specimen numbers of the 
herbs are given in Table 3-1). Chuan Bei was ground into fine powders to prepare 
the extract powder. All other herbs were individually subjected to water extraction. 
500 g each of Huang Qi, Bai Bu and Huang Qin were cut into small pieces and 
boiled with 2.5 1 of distilled water respectively for 1.5 h under reflux. 300 g of Kuan 
Dong Hua was boiled with 3 1 of distilled water for 1 h. The supematants were 
collected and the remaining residue was boiled again with distilled water same as 
before. The supematants were combined with the previous ones and filtered through 
a cotton cloth to remove solid debris. The filtrate was then centrifuged at 4,700 x g 
for 20 min (Beckman Allegra X-15R) and filtered to remove undissolved 
components. The filtrate was frozen and lyophilized into dry powder by 
freeze-drying (Virtis Freezemobile freeze-dryer, Gardiner, NY, USA). A total amount 
of 1.5 kg of each herb had been extracted with water. The extraction efficiency was 
calculated by comparing the final weight of extract obtained with the initial weight of 
raw herb used. The extraction efficiencies of Huang Qi, Huang Qin, Bai Bu and 
Kuan Dong Hua were shown in Table 3-1. 
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3.2,2 Antigen sensitization, challenge, and treatment 
Eighty specific pathogen free, 6-week-old male SD rats (70-90 g) were supplied 
by the Laboratory Animal Services Center of the Chinese University of Hong Kong. 
They were randomly assigned to one of the eight experimental groups (10 rats per 
group): (1) HDM control group, (2-6) five herb treatment groups treated with Huang 
Qi, Bai Bu, Chuan Bei, Huang Qin and Kuan Dong Hua respectively, (7) 
dexamethasone (DXA) treatment group and (8) the niave group. Except naive group, 
all rats were sensitized by intraperitoneal {i.p.) injections of 0.5 ml and subcutaneous 
O.c.) injections of 1.2 ml of HDM-A1(0H)3 suspension (containing 30 |_ig/ml HDM 
and 10% A1(0H)3 in saline) on Days 1 and 3 as described in Section 2.2.5. Fifteen 
and twenty-one days after the last sensitization (Days 18 and 24)，rats were 
anesthetized and challenged intratracheally with 50 jag of HDM in 100 |al of saline as 
described in section 2.2.6. The naive group was sensitized and challenged with 
normal saline using the same procedures. For the five herb treatment groups, each 
herbal extract was dissolved in distilled water (Chuan Bei extract was suspended in 
distilled water) and a dosage of 6.19 g raw herb/kg was administered daily to each rat 
by intragastic feeding for 22 consecutive days from the day following the second 
sensitization (Days 4 to 25). Intragastric feeding was performed by means of 
16-gauge stainless steel feeding needle (Popper & Sons, New Hyde Park, NY, USA). 
Rats in the HDM control group and naive group received daily intragastric distilled 
water. Rats in the DXA group treated with DXA 0,5 mg/kg daily for 10 days {Days 
16 to 25) served as a positive control. DXA was prepared by dissolving 
dexamethasone 21 -phosphate (Sigma-Aldrich) in sterile saline solution and then 
administered to rats by intragastric feeding. The experimental protocol of this study 
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was shown in Figure 3-1. 
3.2.3 Bronchoalveolar lavage and cell differential counts 
Forty-eight hours after the last HDM challenge {Day 26)，all rats were sacrificed 
with an overdose of ketamine and xylazine. The right lung lobes were lavaged with 
6.0 ml of ice-cold PBS as described in section 2.2.7 and the BALF collected were 
centrifuged at 1,500 rpm for 10 min. The supernatant was frozen at -80°C until 
cytokine analysis. The BAL cell pellets were processed as described in section 2.2.7. 
The total number of BALF cells (per ml BALF return) was determined using a 
hemacytometer. Differential BALF cell counts were determined by microscopic 
evaluation of at least 200 cells per Wright-Giemsa-stained cytospin preparation. 
3.2.4 Histological Studies 
The left lungs were fixed in 10% neutral buffered formalin, dehydrated and 
embedded in paraffin. Sections of five microns thick were cut from the 
paraffin-embedded tissue blocks and were stained with hematoxylin and eosin (H&E) 
to examine for infiltrating cells, Congo Red for identification of eosinophils, and 
periodic acid-Schiff (PAS) for identification of mucus-containing cells, and were 
examined under light microscopy. Histological analysis was performed as described 
in section 2.2.8. 
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3.2.5 Measurement of BALF cytokines and chemokines 
The concentrations of rat IL-4, IL-6, IL-10, IFN-y, TNF-a, and MCP-1 in 
BALF were measured by ELISA as described in section 2.2.9. 
3.2.6 Body weight, thymus index and spleen index 
The body weight of all rats was recorded during the experimental period. 
Thymus and spleen of each rat were removed and weighted at sacrifice. Thymus 
(spleen) index (mg/g) was calculated as the ratio of weight of thymus (spleen) / body 
weight. 
3.2.7 Statistical analysis 
All the values were expressed as the mean 土 S.E.M. Statistical analysis was 
performed using SigmaStat program v.3.1 (SPSS, Chicago, IL，USA). Comparisons 
between the groups were done by the Kruskal-Wallis test followed by pairwise 
comparison using the Mann-Whitney U test if the Kruskal-Wallis test was significant. 
Body weight, thymus index and spleen index were analyzed by one-way analysis of 
variance (ANOVA) followed by Least Significant Difference (LSD) multiple 




3,3,1 Effect of herbs and DXA on total cells and eosinophils in BALF 
We aim to study the effects of herb and DXA on the airway inflammation 
induced by HDM {Der f ) . Rats were induced inflammation by HDM according to the 
sensitization and challenge protocol and received treatment with different herbs or 
DXA starting before the antigen challenge. Rats were sacrificed 48 h after the last 
challenge. BALF were collected to determine the cell numbers. HDM sensitization 
and challenges of rats with water treatment (HDM control group) induced a 
significant increase in total cell count compared with the naive rats (25.7 士 2.2 vs 5.0 
土 0.9 X 1 oVml, PO.OOl). The increase in total cell number was significantly 
suppressed by DXA treatment (P<0.05). For the herb treatment, Chuan Bei 
significantly lowered the total cell count to 19.1 士 4.7 x lOVml (尸<0.05). The 
changes in other treatment groups were not statistically significant. Chuan Bei and 
Kuan Dong Hua-treated rats had a slight decrease in total cell counts in BALF 
(Figure 3-2A). 
The absolute number of eosinophils in BALF in the control rats was 
significantly higher than that of naive rats (29.4 士 4.0 vs 0.1 土 0.1 x lOVml,户<0.01). 
The increase of eosinophils was completely abolished following DXA treatment 
(P<0.01). Although all the herb treatment groups had no significant change in 
eosinophils, Chuan Bei and Kuan Dong Hua inhibited the number of eosinophils in 
BALF remarkably by 52.3% (P=0.082) and 36.9% (P=0.095) respectively. Bai Bu 
and Huang Qin-treated rats showed a small increase in eosinophil number compared 
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to control (Figure 3-2B). 
3.3.2 Effect of herb and DXA on lung histology 
The effect of herb and DXA on airway inflammation was also evaluated by 
histological examination. Lung sections were stained with H&E and inflammation 
scores were calculated as described in Materials and methods. In the untreated HDM 
sensitized/challenged rats, marked peribronchial and perivascular inflammatory 
infiltrates were found in the lung sections. In contrast, no inflammatory signs were 
observed in lung sections from naive rats. Treatment of HDM sensitized/challenged 
rats with the five herbs had no detectable effects, whereas DXA treatment 
significantly suppressed the inflammatory cells infiltration compared to control and 
the histology was comparable to that in the naive group (Figure 3-6). The 
inflammation score was significantly higher in the control than in naive group (2.8 土 
0.2 vs 0.5 土 0.2，P<0.0\). All treatments had no significant effect on the 
inflammation scores, except that DXA significantly reduced the inflammation score 
compared to control (/'<0.01) (Figure 3-3). 
Lung sections were stained specifically for eosinophils and peribronchial 
eosinophils were quantitated. The number of eosinophils was significantly increased 
in untreated HDM sensitized/challenged rats compared to naive rats (82.6 士 7.4 vs 
1.8 土 1.1，PO.Ol). The increase of eosinophils was completely suppressed by DXA 
(/^=0.001) while no significant change was observed in all other treatment groups 
compared to control (Figure 3-4 and 3-7). There was a slight decrease in eosinophil 
number in Chuan Bei group. 
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In addition, lung sections were stained with PAS for evaluation of goblet cell 
hyperplasia. Goblet cells were virtually absent in the naive rats. HDM sensitized/ 
challenged rats developed marked goblet cell hyperplasia (Figure 3-8). The goblet 
cell score was significantly higher in the control than in naive group (1.6 ±0.1 vs 0.2 
土 0.2，尸<0.01). All treatments had no significant effect on the goblet cell score, 
except DXA treatment which was shown to significantly suppressed the goblet cell 
hyperplasia compared to control (P<O.Q\) (Figure 3-5 and 3-8). There was only a 
slight decrease in goblet cell score in Huang Qin and Chuan Bei groups. 
3.3,3 Effect of herbs and DXA on cytokine and chemokine level in BALF 
The effect of herb and DXA treatment on the level of cytokines and chemokine 
was investigated 48 h after the final HDM challenge. IL-4 level in BALF of control 
rats was significant higher than that of naive rats (4.2 ± 1.1 vs 1.5 ± 0.4 pg/ml， 
P<0.05). The increase of IL-4 was completely suppressed following DXA treatment 
CP=0.01). Treatment with Kuan Dong Hua significantly reduced IL-4 level to 1.9 士 
0.3 pg/ml (P<0.05). Huang Qi and Bai Bu also markedly inhibited IL-4 in BALF by 
48.7% and 56.7% respectively, although the differences were not statistically 
significant compared with control (P=0.152 and P=0.093). Chuan Bei and Huang 
Qin had no effects on IL-4 level (Figure 3-9). 
IFN-y level in BALF of control rats was significantly higher than that of naive 
rats (61.7 土 7.6 vs 13.6 士 4.2 pg/ml,尸<0.001). There was a slightly increased level of 
IFN-y in all the herb treatment groups, but the differences were not statistically 
significant compared to control. The IFN-y levels in different groups of rats treated 
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with Huang Qi, Bai Bu, Chuan Bei，Huang Qin and Kuan Dong Hua were 64.4 士 
22.7 pg/ml, 68.1 土 22.3 pg/ml，73.5 士 9.0 pg/ml, 69.3 土 15.5 pg/ml and 78.9 士 17.6 
pg/ml respectively. In contrast, IFN-y level was almost completely suppressed 
following DXA treatment (PO.OOl) (Figure 3-12). 
IL-6 level in BALF of control rats was significant higher than that of naive rats 
(324.0 土 68.4 vs 113.1 土 18.7 pg/ml,户<0.001). IL-6 was completely suppressed 
following DXA treatment (户<0.001). Treatment with Kuan Dong Hua significantly 
reduced IL-6 level to 140.1 士 9.6 pg/ml (尸<0.01). IL-6 was also decreased in all 
other herb treatment groups, but the differences were statistically insignificant 
compared to control. IL-6 was decreased by 46.8%, 36.1%, 28.4% and 24.8% in the 
Bai Bu, Huang Qi, Chuan Bei and Huang Qin group respectively (Figure 3-10). 
IL-10 level in BALF of control rats was significant higher than that of naive 
rats (168.7 土 44.2 vs 17.7 土 5.3 pg/ml, P<0.001). IL-10 was completely suppressed 
following DXA treatment (P<0.001). Huang Qin and Kuan Dong Hua significantly 
reduced IL-10 level to 73.3 土 14.4 pg/ml and 48.9 士 8.0 pg/ml respectively (尸<0.05 
and 户<0.001). IL-10 level was reduced by half in the BALF of Huang Qi group 
compared with control, but the difference was not significant. Other herbs had no 
effects on IL-10 levels (Figure 3-11). 
MCP-1 level in BALF of control rats was significant higher than that of naive 
rats (826.2 土 95.0 vs 80.4 土 12.8 pg/ml, P<0.01). In contrast to other cytokines, 
MCP-1 level was unchanged following DXA treatment (P=0.731). Chuan Bei and 
Kuan Dong Hua significantly reduced MCP-1 level to 407.4 土 60.0 pg/ml and 481.1 
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士 125.6 pg/ml respectively (P<0.0\ and P<0.05). MCP-1 level was reduced by 
20.9% and 8.8% in Huang Qi and Bai Bu groups respectively compared with control, 
but the changes were relatively small and not significant. Huang Qin had no effects 
on MCP-1 level (Figure 3-13). 
TNF-a level in BALF of all groups were below the detection limit of the ELISA 
assay. Therefore, effect of herbs and DXA on TNF-a was not determined in the 
present study. 
3.3.4 Effect of herb and DXA on body weight, thymus index and spleen index 
The body weight of rats was recorded during the experimental period. 
Inflammation induced by HDM resulted in a reduction in body weight. Significant 
change in body weight was seen on day 26 as compared to the naive rats (231.2 士 9.9 
vs 263.3 土 12.0 g，尸<0.01). DXA treatment resulted in a drop in body weight 
compared to control group, which was significant different on day 26 (162.0 士 3.8 g 
vs 231.2 土 9.9, P<0.001). In contrast, body weight of all the herb treatment groups 
did not change significantly compared to control group on both day 18 and 26 
(Figure 3-14A). 
Thymus and spleen indices were also determined. Spleen index but not thymus 
index was significantly increased in control compared to naive rats (3.2 土 0.3 vs 2.3 
±0.1，户<0.01). DXA treatment resulted in a marked and significant decrease in both 
thymus index and spleen index compared to control, indicating severe 
immunosuppression (0.5 土 0.0 vs 2.2 土 0.2 and 1.6 ± 0.1 vs 3.1 士 0.3，both were 
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/^�O.OOl). In contrast, thymus and spleen indices of all the herb treatment groups did 




Asthma is a chronic inflammatory disease of the airways. It is known that in 
asthma patients, airway inflammation participate in the mechanisms leading to 
airway obstruction, increased mucus production and increase in AHR (Eum et al, 
1996). Airway inflammation is associated with the infiltration of eosinophils, 
lymphocytes and mast cells in the airways. Increased numbers of these cells have 
been found in the BALF and bronchial biopsy samples from asthmatic patients (Kay, 
1991). 
The HDM-induced rat model was prepared according to the sensitization and 
challenge protocol as described in the previous chapter, but two intratracheal 
challenges were used instead of three in this study. This modification was made 
because we observed a high mortality of rats during the intratracheal challenge 
procedure that would reduce our sample size and the allergic responses after two or 
three challenges were similar. Since previous smdies have showed that herbal 
medicines were effective when they were administered before antigen challenge (Li 
et al., 2004)，we applied the herbal or drug treatment prior to the first HDM 
challenge till the end of the experiment. Rats were treated either with the single herbs 
for 22 consecutive days after the second sensitization or dexamethasone (DXA) for 
the last 10 days. Our previous study has compared three different dosages of CUF2 
and found that the dosage of 6.19 g/kg (in total raw herb) produced the most 
prominent effects in asthmatic rats (Wong et al., 2006). Therefore, we continued to 
use this dosage of herbs in the present study. 
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In our study, the HDM-induced control rats showed a number of features typical 
of human allergic asthma, including infiltration of inflammatory cells, particularly 
eosinophils in the BALF and lung tissue, goblet cell hyperplasia, as well as a 
significant increase of the levels of various cytokines and chemokine (IL-4, IL-6, 
I L - 1 0 , IFN-Y a n d M C P - 1 ) in B A L F . 
Our data showed that among all the herbs, only treatment with Chuan Bei 
resulted in a significant reduction in the total inflammatory cells in BALF. Other 
herbs had no significant effect on the total cellular infiltration in BALF. Furthermore, 
the effect of herb treatment on the infiltration of inflammatory cells in the lung tissue 
was investigated. We found that treatment with all the herbs, including Chuan Bei, 
did not appear to affect the histological features of lung inflammation induced by 
HDM. 
Moreover, we studied the effect of herb treatment on the eosinophil infiltration 
in BALF and the lung tissue. We found that, again, treatment with all the herbs did 
not result in a significant reduction of eosinophils both in the BALF and lung tissue. 
Although treatments with Chuan Bei and Kuan Dong Hua produced a decrease in 
eosinophil numbers in BALF, the decrease was not statistically significant compared 
to control (P=.082 and .095 respectively). 
We also studied the effect of herb treatment on goblet cell hyperplasia in the 
HDM model. We found that all the herb treatments did not show any significant 
effects on the reduction of percentages of goblet cells in the airways. Goblet cells are 
observed in chronic airway inflammatory conditions and contribute to mucous 
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plugging and bronchiolar obstruction (Rogers, 2002). The airways of healthy 
subjects contain few goblet cells (Shimura et al,, 1996). 
We found that, despite prominent effects of CUF2 in the reduction of 
inflammatory response shown in our previous study, the extract of each individual 
herb including Kuan Dong Hua seemed to have little effect on the inflammatory cell 
infiltration in the HDM-induced rat model of asthma. Since we did not repeat the 
study using the extract of CUF2 mixture, we cannot be sure whether the lack of 
effect of each individual herb was due to the loss of synergistic effects with other 
component herbs. However, further investigations are needed to examine this 
possibility. Second, the dosage of each herb used in this study may be not adequate to 
be effective on its own. In the present study, it would be difficult to administer the 
herb extract especially Chuan Bei at a higher dosage by oral gavage. A higher dose of 
herbs may be required to produce the anticipated results. 
The HDM-induced airway inflammation also elicited a number of inflammatory 
factors which may play a crucial role in the pathogenesis of asthma. Although all the 
herb treatments had no detectable effect on the pathological features of the model, 
some of them showed inhibitory effects on the cytokines and chemokine production 
in BALF in the sensitized rats. 
We found that treatment with Kuan Dong Hua significantly inhibited the 
production of pro-inflammatory cytokines and chemokine in BALF including IL-4, 
IL-6, IL-10 and MCP-1. Evidence shows that Th2 cytokines produced by the Th2 
lymphocytes are the central mediators of asthma (Robinson et al., 1992). They are 
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responsible for the development of pulmonary eosinophilia, mucus hypersecretion, 
and AHR (Ritz et al, 2000). The Th2-derived cytokine, IL-4, is important in 
initiating the asthmatic response by regulating the production of IgE and promoting 
the differentiation of T lymphocytes to a Th2 phenotype (Chung and Barnes, 1999). 
IL-6 may participate in pathogenesis of asthma. Levels of IL-6 are also increased in 
BALF from patients with allergic asthma after allergen challenge (Yokoyama et al., 
1997). The role of IL-10 in asthma remains controversial (Makela et al” 2002). IL-10 
is often regarded as a Th2 cytokine and is shown to contribute to asthma by 
enhancing AHR and allergic inflammation (Yang et al,, 2000). IL-10 suppresses the 
development of Thl lymphocytes and enhances B cells proliferation and IgE 
synthesis (Kim et al., 1992). The chemokine MCP-1 may also play a role in allergic 
asthma by driving the undifferentiated T cells towards an IL-4 producing Th2 type of 
cell (Lloyd, 2002). Therefore, inhibition of these cytokines and chemokine by Kuan 
Dong Hua may have therapeutic potential in the treatment of asthma. 
Besides, various effects were shown by the other herb extracts. Huang Qi and 
Bai Bu strongly inhibited IL-4 comparable to Kuan Dong Hua, however the 
differences were not significant compared to control. Huang Qi also markedly 
inhibited IL-10, although again not significant. On the other hand, Chuan Bei and 
Huang Qin were found to significantly inhibit MCP-1 and IL-10 respectively. 
Furthermore, all of these herbs produced a marked inhibition of IL-6, however no 
significant difference was observed. 
It is now well established that asthma is a disease characterized by excess 
production of Th2 cytokines (e.g. IL-4, IL-5, IL-13) relative to Thl cytokine (IFN-y) 
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(Lee et al., 2005). Overproduction of Th2 cytokines by Th2 cells elicits an allergic 
response. On the contrary, Thl cells which produce IFN-y have been shown to inhibit 
the production of IL-4 by Th2 cells (Gajewski et al, 1989). IFN-y has inhibitory 
effects on the Th2-induced airway eosinophilia and AHR in mice (Cohn et al,’ 1999). 
In this study, IFN-y level in BALF was significantly increased in the HDM control 
group. Such increase may be caused by the local inflammatory response or activation 
of Thl cells following antigen challenge. Treatment with all the herbs showed a 
slight increase of IFN-y level compared with the HDM control group, although the 
differences were not significant. 
The present results showed that Kuan Dong Hua could modulate the Th2/Thl 
response in the HDM-induced rat model of asthma. Our studies demonstrated for the 
first time the immunomodulatory effects of Kuan Dong Hua which may be a 
potential mechanism for asthma treatment. Furthermore, Huang Qi and Bai Bu 
appeared to exert some immunomodulatory effect on the Th2/Thl response by 
down-regulating the Th2 response, although the effects were not significant. Thus, 
the results suggested that these herbs may be potential therapeutic medicine for 
treatment of asthma. Despite the in-vivo effects of cytokines modulation shown by 
some of the herbs，none of these herb treatments showed a reduction of the 
inflammatory cell infiltration in the HDM-sensitized rats. Further investigations are 
required to determine the precise anti-asthma mechanisms of these herb extracts. 
DXA was used as a positive control drug in this study. It is one of the most 
potent anti-inflammatory corticosteroids and acts by inhibiting leukocyte migration 
into sites of inflammation and the synthesis of pro-inflammatory cytokines and 
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chemokines (Schleimer et al.’ 1990). Their inJiibitory actions on the recruitment of 
eosinophils account for their therapeutic effect (Eum et al” 2003). As expected, 
treatment with DXA significantly suppressed pulmonary inflammation, eosinophil 
infiltration in BALF and lung tissue, goblet cell hyperplasia as well as cytokine 
production in BALF after HDM challenges. DXA treatment significantly suppressed 
the production of IL-6, IL-10, as well as both IL-4 and IFN-y, to the levels of 
saline-challenged subjects. However, DXA treatment showed no significant effect on 
MCP-1 level compared with control, while the reason for this was unknown. 
DXA suppressed both Thl (IFN-y) and Th2 (IL-4) responses. In contrast to 
DXA, all the herb treatments did not significantly affect IFN-y production and hence 
they act via a different mechanism to that of DXA. These herbs may have advantages 
over DXA that they are less likely to increase the susceptibility to infection in 
patients. Moreover, in this study, DXA treatment produced severe side effects 
including significant reduction in body weight, thymus index and spleen index. On 
the contrary, all the herb treatments did not show a significant change in body weight 
or immunosuppression as observed in DXA group. 
In conclusion, our results showed that administration of the individual herbs in 
the HDM-sensitized rat model, in general, had no apparent effects on cell counts in 
BALF and lung tissue. However, we found that Kuan Dong Hua exhibited potent 
immunomodulatory effects on the Th2/Thl responses in the asthma model. This 
study suggests that Kuan Dong Hua is a potentially useful herb to treat asthma. The 
therapeutic activity of this herb may be partly related to its immunomodulatory 
effects. Further studies are required to determine whether Kuan Dong Hua would 
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have synergistic effects with the four other herbs of CUF2. 
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Time (Day) 1 3 18 24 26 
HDM Sensitization Challenge Analysis 
I 1 I 1 
~ \ pt pt 2nd 
Day 4 
Five treatment herbs n ^^  , 
22 days 
or Water � 
Day 16 ^ 
DXA, 10 days 
Figure 3-1. Experimental protocol. Rats were sensitized i.p. and s.c. with HDM 
twice on days 1 and 3, and then challenged intratracheally on days 18 and 24. 
Twenty-four hours after the second sensitization, rats were treated with Huang Qi, 
Bai Bu, Chuan Bei, Huang Qin, Kuan Dong Hua (6.19 g/kg/d respectively), or 
distilled water (HDM control) intragastrically for 22 consecutive days. DXA-treated 
rats received DXA 0.5 mg/kg daily for the last 10 days. Naive rats served as 
additional control. Rats were killed 48 h after the last HDM challenge. 
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Table 3-1. The voucher specimen numbers and extraction efficiencies of the five 
herbs used in the present study. 
Chinese herbs Voucher specimen Extraction 
numbers efficiency (w/w) 
Bulbus fritillariae cirrhosae (Chuan Bei) 2005-2785 None 
Radix astragali (Huang Qi) 2005-2786 14.4% 
Radix Scutellariae (Huang Qin) 2005-2787 20.8% 
Radix stemonae (Bai Bu) 2005-2788 28.2% 




























































































Figure 3-2. Effect of herb and DXA treatment on (A) total leukocyte and (B) 
eosinophil numbers in BALF 48 h after the last challenge in sensitized rats. Groups 
of HDM sensitized and challenged rats were treated with the indicated herbs (6.19 
g/kg/d) for 22 consecutive days after the second sensitization or DXA (0.5 mg/kg/d) 
for the last 10 days as described in Materials and Methods (Section 3.2.2). Naive rats 
were saline sensitized and challenged treated with distilled water. Values represent 
mean 土 SEM of 4-9 rats. compared to naive rats. ''P<0.05, 
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Figure 3-3. Results of inflammation scores from different groups of rats. HDM 
challenged rats were treated with herbs or DXA as described in legend of Figure 3-2. 
Lungs were collected 48 h after the last challenge. Sections were stained with H&E 
for histological examination. A score of 0-3 was assigned to the tissue sections of the 
rats as described in Material and Methods (Section 2.2.8). Values represent mean 士 
SEM of 5-6 rats per group. compared to saline challenge rats {Naive group), 
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Figure 3-4. Effect of herb and DXA treatment on eosinophil accumulation in the 
bronchial wall. HDM challenged rats were treated with herbs or DXA as described in 
legend of Figure 3-2. Lungs were collected 48 h after the last challenge, sectioned 
and stained with Congo Red for eosinophils. Total number of eosinophils was 
obtained from 4 high power fields (HPF; x400 magnification) per tissue section. 
Values represent mean 士 SEM 
of 5-7 rats per group. 
compared to saline 
challenge rats {Naive group)."尸=0.001 compared to HDM challenged rats treated 
with distilled water {HDMgroup). 
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Figure 3-5. Results of goblet cell score from different groups of rats. HDM 
challenged rats were treated with herbs or DXA as described in legend of Figure 3-2. 
Lungs were collected 48 h after the last challenge. The number of goblet cells in the 
large airways was assessed in the PAS-stained histological sections as described in 
Materials and methods (Section 2.2.8). Values represent mean 士 SEM of 5-6 rats per 
group, t卞P<0.01 compared to saline challenge rats (J^a'ive group). **P<0.01 compared 












Figure 3-6. Representative H&E stained lung sections from different treatment 
groups of rats. Naive rats were saline sensitized and challenged (A). Rats in other 
seven groups were HDM sensitized and challenged treated with water (B), Huang Qi 
(C), Bai Bu (D), Chuan Bei (E), Huang Qin (F), Kuan Dong Hua (G) and DXA (H), 
respectively as described in Methods and Methods (Section 3.2.2). Lungs were 
collected 48 h postchallenge. Magnification: x50. Arrows indicate inflammatory cells. 
AW, airways; BV, blood vessels. 
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Figure 3-7. Representative Congo Red stained lung sections from different treatment 
groups of rats. Naive rats were saline sensitized and challenged (A). Rats in other 
seven groups were HDM sensitized and challenged treated with water (B), Huang Qi 
(C), Bai Bu (D% Chuan Bei (E), Huang Qin (F), Kuan Dong Hua (G) and DXA (H), 
respectively as described in Methods and Methods (Section 3.2.2). Lungs were 
collected 48 h postchallenge. Original magnification: x200. Arrows demonstrate 
accumulation of eosinophils in the submucosa of a bronchus. AL, airway lumen; EP, 
epithelium; SM, smooth muscle. 
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Figure 3-8. Representative PAS stained lung sections from different treatment 
groups of rats. Naive rats were saline sensitized and challenged (A). Rats in other 
seven groups were HDM sensitized and challenged treated with water (B), Huang Qi 
(C), Bai Bu (D), Chuan Bei (E)，Huang Qin (F), Kuan Dong Hua (G) and DXA (H), 
respectively as described in Methods and Methods (Section 3.2.2). Lungs were 
collected 48 h postchallenge. Magnification: xgO. Arrows indicate goblet cells. AW, 
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Figure 3-9. Effect of herb and DXA treatment on IL-4 in BALF 48 h after the last 
challenge in sensitized rats. HDM challenged rats were treated with herbs or DXA as 
described in legend of Figure 3-2. Cytokine concentrations were determined as 
described in Materials and Methods (Section 2.2.9). Values represent mean 士 SEM of 
5-9 rats per group. V<0.05 compared to saline challenge rats {Naive group). *户<0.05， 
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Figure 3-10. Effect of herb and DXA treatment on IL-6 in BALF 48 h after the last 
challenge in sensitized rats. HDM challenged rats were treated with herbs or DXA as 
described in legend of Figure 3-2. IL-6 concentration was determined as described in 
Materials and Methods (Section 2.2.9). Values represent mean 土 SEM of 5-9 rats per 
group.竹t户<0.001 compared to saline challenge rats {Naive group). **P<0.01, 
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Figure 3-11. Effect of herb and DXA treatment on IL-10 in BALF 48 h after the last 
challenge in sensitized rats. HDM challenged rats were treated with herbs or DXA as 
described in legend of Figure 3-2. IL-10 concentration was determined as described 
in Materials and Methods (Section 2.2.9). Values represent mean 士 SEM of 5-8 rats 
per group.竹卞户<0.001 compared to saline challenge rats {Naive group). *P<0.05, 
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Figure 3-12. Effect of herb and DXA treatment on IFN-y in BALF 48 h after the last 
challenge in sensitized rats. HDM challenged rats were treated with herbs or DXA as 
described in legend of Figure 3-2. Cytokine concentrations were determined as 
described in Materials and Methods (Section 2.2.9). Values represent mean 土 SEM of 
5-9 rats per group.竹卞尸<0.001 compared to saline challenge rats {Naive group). 
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Figure 3-13. Effect of herb and DXA treatment on MCP-1 in BALF 48 h after the 
last challenge in sensitized rats. HDM challenged rats were treated with herbs or 
DXA as described in legend of Figure 3-2. MCP-1 concentration was determined as 
described in Materials and Methods (Section 2.2.9). Values represent mean 士 SEM of 
5-8 rats per group. 
compared to saline challenge rats (Naive group). 
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Figure 3-14. Effect of herb and DXA treatment on (A) body weight, (B) thymus 
index and (C) spleen index of HDM challenged rats. HDM challenged rats were 
treated with herbs or DXA as described in legend of Figure 3-2. Body weight was 
monitored during the experimental period. Index of thymus or spleen was determined 
as the ratio of thymus or spleen weight / body weight. Values represent mean 士 SEM 
of 5-9 rats per group. 卞户<0.01 compared to saline challenge rats {Naive group). 





IMMUNOMODULATORY EFFECT OF KUAN DONG 
HUA ON HUMAN MAST CELLS (HMC-1) 
4.1 Introduction 
Kuan Dong Hua has been used for the treatment of bronchitic and asthmatic 
conditions in China for centuries. This herb is known to possess anti-inflammatory 
actions. A previous study of Ryu et al. (1999) has shown that the methanolic extract 
of this herb strongly inhibited nitric oxide synthesis in lipopolysaccharide-activated 
macrophages. Additionally, the extract of Kuan Dong Hua had been shown to have 
complementary anti-inflammatory effects in a clinical trial (Lee et al” 2004). Despite 
the benefits shown in these studies, the precise mechanisms of this herb in treating 
allergic diseases such as asthma have not been well defined. Since we found that 
administration of Kuan Dong Hua had better effect in the inhibition of inflammatory 
cytokine production and attenuation of lung inflammation than the other herb 
extracts in the HDM-sensitized rat model, we studied further its anti-inflammatory 
mechanism by using human mast cell line. Mast cells contain a variety of mediators 
and cytokines which have potential contribution to the process of inflammation. It is 
worth studying the effect of Kuan Dong Hua on mast cells. In the present study, we 
aimed to elucidate its effect on the cytokine secretion (IL-6, IL-8，GM-CSF and 
TNF-a) from the human mast cell line (HMC-1) when the herb extract was added 
into the cell culture medium. 
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4.2 Materials and methods 
4.2.1 Reagents 
4.2.1.1 Chemicals 
All chemicals were purchased from Sigma Chemical Co. (St. Louis, MO, USA) 
unless otherwise stated. 
3-(4,5-dimethylthiazol-2'yl)-diphenyltetrazolium bromide (MTT) 
MTT reagent was prepared by dissolving the compound at 5 mg/ml in sterile 
PBS (See preparation in section 2.2.1) and stored at 4°C until use. 
Phorbol 12-myristate 13-acetate (PMA), calcium ionophore A23187 and polymyxin 
B sulfate (PMB) 
Stock solutions ofPMA (250 ^ig/ml) and A23187 (6.25 x lO*^  M) were prepared 
by dissolving the respective compounds in DMSO. A stock solution of PMB (4 x 10^  
U/ml) was prepared by dissolving the compound in sterile PBS. Aliquots of them 
were stored at -20°C until use. 
4.2J.2 Cell culture medium, serum supplements and antibiotic mixture solution 
were purchased from Gibco BRL Life Technologies, Inc. (Carlsbad, CA, USA). 
4.2.1.3 Limulus amoebocyte lysate (LAL) kit was purchased from Associates of 
Cape Cod, East Falmouth, MA. 
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4.2.1,4 ELISA reagents were purchased from Pharmingen (San Diego, CA, USA). 
4.2.2 Cell line and Cell Culture 
The human leukemic mast cell line (HMC-1) was kindly provided by Dr. Joseph 
H. Butterfield (Mayo Clinic, Rochester, MN). HMC-1 cells were grown in Iscove's 
Modified Dulbecco's Medium (IMDM) containing 2 mmol/L L-glutamine, 
supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% antibiotics (100 
U/ml of penicillin and 100 |ag/ml of streptomycin) at 37�C in a humidified 
atmosphere of 5% carbon dioxide air. Cells were passed every 3 to 4 days using 
sterile technique. 
4.2.3 Herb and extraction procedure 
Kuan Dong Hua was purchased from a local herb supplier. A voucher specimen 
of the herb (voucher specimen number: 2005-2707) was deposited at the museum of 
Institute of Chinese Medicine, The Chinese University of Hong Kong. The water 
extract of Kuan Dong Hua was prepared by decocting 300 g of the dried herb in 3 1 
of boiling distilled water under reflux for 1 h twice. The two parts of aqueous extract 
were combined, filtered through a cotton cloth and centrifuged at 4,700 x g for 20 
min. (Beckman Allegra X-15R). The supernatant was then concentrated using a 
rotary evaporator, and then frozen and lyophilized into dry-powder by freeze-drying 
(Virtis Freezemobile freeze-dryer, Gardiner, NY, USA). The yield of extraction was 
about 45% (w/w). For the cell culture study, the extract was dissolved in IMDM 
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containing 10% heat-inactivated (56°C for 30 min) FBS，100 U/ml penicillin and 100 
fig/ml streptomycin and filtered with 0.22 \xm syringe filter before use. The doses 
mentioned in the text refer to the weight of the final powdered extract. 
4,2,4 Cell Viability Assay 
Cell viability was determined by the MTT dye-reduction assay as described 
previously with slight modifications (Kim et al., 2001). 100 fil of HMC-1 cells 
suspension (2 x 104 cells/well) was seeded on 96-well plates in IMDM containing 
10% heat-inactivated FBS, 100 U/ml penicillin and 100 |ig/ml streptomycin and 
treated with 100 [i\ of Kuan Dong Hua extract with the final concentrations from 
0.3125-5 mg/ml. The cells were incubated for 24 h at 37°C with 5% CO2 after 
stimulation with 50 ng/ml PMA plus 2.5 x 10'^  M calcium ionophore A23187. Cells 
incubated in the absence of extract (medium alone) and stimulated with PMA plus 
A23187 served as control. Following incubation, the medium was aspirated and 
replaced with fresh medium plus 20 |il/well MTT reagent and the cells were 
incubated at 37°C for an additional 4 h. After this, the plates were centrifuged at 
3,700 rpm for 5 min and the supernatant was aspirated. The insoluble formazan 
product was dissolved in 100 |al/well of dimethyl sulfoxide (DMSO) and the plates 
were shaken gently for 10 min. Then, the optical density at 570 nm was read using a 
spectrophotometer (Fluostar Optima; BMG Labtechnologies GmbH, Offenburg, 
Germany). The sample absorbance values were obtained by subtracting the blank 
(medium without cells). Results were expressed as percentage of viability relative to 
control, which was taken as 100%. 
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4.2.5 Assay of cytokine secretion 
500 |al of HMC-1 cells suspension (1 x 10^  cells/well) was seeded on 48-well 
plates in IMDM containing 10% heat-inactivated FBS, 100 U/ml penicillin and 100 
|ag/ml streptomycin. Previous research has shown that preincubation of the HMC-1 
cells with other drugs for 1 h before stimulation results in significant inhibition of 
cytokines, and the inhibitory effect is more marked compared with coincubation of 
stimuli and drug (Lippert et al., 2000). Therefore, in this study, the cells were 
pretreated with 500 |il of Kuan Dong Hua extract with the final concentrations from 
0.625-2.5 mg/ml for 1 h at 37�C with 5% CO2 atmosphere prior to stimulation with 
50 ng/ml PMA plus 2.5 x 10'^  M calcium ionophore A23187 and were incubated 
further for 6 and 24 hours respectively. Cells incubated in culture medium alone and 
stimulated with PMA plus A23187 served as control. Another set of cells were 
neither preincubated with the extract nor subjected to stimulation with PMA plus 
A23187. The viability of cells incubated with the tested concentrations of extract was 
always greater than 80%, as determined by MTT assay. 
4.2.6 Quantitative Analysis of cytokines 
After 6 and 24 h of incubation, the cells were centrifuged and the concentrations 
of IL-6, IL-8, GM-CSF and TNF-a cell-free supernatant were determined by ELISA 
using the commercially available human ELISA sets (Pharmingen, San Diego, CA, 
USA), according to the manufacturer's instructions. The procedures were same as 
described in section 2.2.9. The detection limits were 3.1 pg/ml for IL-8, 4.7 pg/ml for 
IL-6 and GM-CSF and 7.8 pg/ml for TNF-a. No detectable cross-reactivity with 
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Other cytokines has been reported for the ELISA kits used. Results were calculated as 
percentage of inhibition of cytokine release with reference to control by the formula: 
% Inhibition = (a - b) x 100/a, where ‘a, is cytokine concentration in untreated 
control and ‘6’ is cytokine concentration with extract treatment. 
4.2.7 Bacterial endotoxin contamination 
The various concentrations of extract were tested for the presence of bacterial 
endotoxin by a Limulus amoebocyte lysate (LAL) gel clot test with a sensitivity of 
0.25 EU/ml. The test was performed by adding 0.2 ml of the samples to single test 
vials of lyophilized LAL. Following 1 h incubation at 37°C, the tubes were inverted 
180° in one smooth motion. The formation of a stable gel-clot in the bottom of the 
tube indicated a positive test; an endotoxin concentration greater than or equal to the 
sensitivity of the LAL reagent. If no gel formed or a gel had formed but broke or 
collapsed upon inversion, the test was negative indicating an endotoxin concentration 
less than the sensitivity of the LAL reagent. Standard endotoxin and pyrogen-free 
water were used as positive and negative controls respectively. 
In addition, the effect of endotoxin contamination was checked using an 
endotoxin inhibitor, polymyxin B (PMB). The HMC-1 cells treated with the highest 
concentration of extract (2.5 mg/ml) were also combined with PMB (100 U/ml) to 
examine the possible effect of LPS contamination on cytokine secretion. 
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4,2,8 Statistical analysis 
Each datum represents the mean 士 S.D. or S.E.M. of triplicate determinations 
from three independent experiments under the same conditions. The Student's Mest 
was used to make a statistical comparison between the groups. All statistical analyses 
were performed using Graphpad Prism software v.4.0 (GraphPad Software, San 




4.3.1 Effect of Kuan Dong Hua on cell viability of HMC-1 
The viability of HMC-1 cells was determined following 24 h of incubation with 
Kuan Dong Hua extract after PMA plus A23187 stimulation. The viability of HMC-1 
was greater than 80% when concentration of Kuan Dong Hua was below 5 mg/ml 
(Figure 4-1). Therefore, we used the concentrations of 2.5, 1.25 and 0.625 mg/ml of 
Kuan Dong Hua in the cytokine assay to prevent cytotoxic effects of extract on 
HMC-1. 
* 
4.3.2 Effect of Kuan Dong Hua on cytokine release from HMC-1 
The production of IL-6, IL-8，GM-CSF and TNF-a in the HMC-1 media 
incubated with various concentrations of Kuan Dong Hua extract was assayed 
quantitatively by ELISA. The results are shown as percentage of inhibition of 
cytokine release with reference to control in Figure 4-2 (A — D). Kuan Dong Hua 
showed an inhibitory effect on IL-6 release at 2.5 mg/ml at 6 h (P<0.01), while no 
effects were seen at lower concentrations. However, stimulatory effects on IL-6 
release were observed at 0.625 and 1.25 mg/ml at 24 h (both are 尸<0.01) while no 
effect was shown at 2.5 mg/ml. For the IL-8 release, Kuan Dong Hua showed 
dose-dependent inhibitory effects at both 6 and 24 h, with the inhibitory effect 
greater at 24 h compared to 6 h. Significant differences were detected at 2.5 mg/ml at 
both time points (P<0,05 and P<0.0\ respectively). For the release of GM-CSF, 
Kuan Dong Hua showed a dose-dependent inhibitory effect at 6 h, with significant 
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differences detected at 1.25 and 2.5 mg/ml (P<0.05 and ？<0.01 respectively). 
Inhibitory effect was also shown at 2.5 mg/ml at 24 h (PO.Ol), while no effects were 
observed at lower concentrations. Similarly, Kuan Dong Hua showed a 
dose-dependent inhibitory effect on the release of TNF-a at 6 h，with significant 
difference at 2.5 mg/ml (PO.Ol). Inhibitory effect was also shown at 2.5 mg/ml at 
24 h (P<0.01), while no effects were seen at the lower concentrations. 
4.3,3 Effect of endotoxin contamination in the extract 
The endotoxin levels in the Kuan Dong Hua solution samples of 0.625, 1.25 and 
2.5 mg/ml were all below the test sensitivity of 0.25 EU/ml in the LAL test. The 
amount of endotoxin present in Kuan Dong Hua was considered negligible when 
used at 2.5 mg/ml. 
In addition, the effect of endotoxin present in the herbal extract was checked 
using an endotoxin inhibitor PMB. PMB (100 U/ml) was added into the HMC-1 
medium with 2.5 mg/ml extract to examine if the inhibitory effect of the extract was 
affected. There were no significant differences in the release of IL-6, GM-CSF and 
TNF-a between the two groups with or without PMB except that the inhibition of 
IL-8 release by the extract was suppressed by PMB at 6 and 24 h (尸<0.05 and 
PO.Ol respectively) (Figure 4-2). After combining with PMB, the inhibitory effect 
on IL-8 release of the extract was only significant at 24 h (P<0.05) but not at 6 h. 
Inhibitory effects on IL-6 at 6 h and GM-CSF and TNF-a at 6 and 24 h were not 




Mast cells contain potent mediators, including histamine, proteinases, 
leukotrienes，and multifunctional cytokines that play an important role in the 
pathogenesis of asthma (Choi et al, 2005). Kuan Dong Hua has been used for 
treatment of asthma in China for centuries. However, the pharmacological 
mechanism of this herb has not been well characterized. In the present study, the 
inhibitory effect of Kuan Dong Hua on PMA plus A23187-induced production of 
cytokines in human leukemic mast cells (HMC-1) was investigated. The HMC-1 has 
become a useful in vitro model for study of mast cells since its establishment by 
Butterfield et al (1988). Although HMC-1 has disadvantages due to its immaturity in 
some aspects like morphology and histamine contents, it exhibits most of the features 
of its mature counterparts such as the secretion of cytokines (Lippert et aL, 2000). 
IL-6, IL-8, GM-CSF and TNF-a are known to be key cytokines that contribute to 
inflammation in asthma. They were chosen to elucidate the effect of Kuan Dong Hua 
when the herb extract was added to the cell culture medium. 
Our data showed that Kuan Dong Hua has inhibitory effect on IL-6 release at 
2.5 mg/ml at early incubation but stimulatory effect was noted at lower 
concentrations when incubated for 24 h. IL-6 is an important cofactor in 
IL-4-dependent IgE synthesis. There is increased release of IL-6 from alveolar 
macrophages in patients with asthma after allergen challenge and increased basal 
release compared with non-asthmatic subjects (Chung and Barnes, 1999). The reason 
for the different effects of Kuan Dong Hua on IL-6 production is unclear. It might be 
due to different substances present in the herb extract that produce different effects. 
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However, further study is needed to verify the effect of herb on IL-6 production in 
HMC-1. On the other hand, we demonstrated that Kuan Dong Hua has potent 
inhibitory effect on IL-8, GM-CSF and TNF-a secretion from HMC-1 cells. The 
inhibitory effect of IL-8 was dose-dependent at both incubation times while that of 
GM-CSF and TNF-a was dose-dependent only at early incubation. Significant 
inhibitory effects were detected mostly at the highest concentration of extract (2.5 
mg/ml) at both incubation times. The inhibitory effects shown at 24 h were not 
higher than that of 6 h except that the inhibitory effect of IL-8 by the extract was 
more marked at 24 h of incubation. IL-8 acts as a neutrophil chemoattractant and 
activator. Free IL-8 has been detected in the sera and bronchial tissue of patients with 
severe atopic asthma but not in healthy subjects or those with mild atopic asthma, 
suggesting that IL-8 may be a marker of severe asthma (Shute et al., 1997). In 
addition, there are increased levels of IL-8 measured in the BALF of patients with 
asthma and bronchitis (Chung and Barnes, 1999). GM-CSF is one of the most 
important mediators because of its ability to attract and activate eosinophils and 
prolong their survival. Increased GM-CSF expression has been found in the 
bronchial epithelium of asthmatic patients and in T lymphocytes and eosinophils 
after allergen challenge (Chung and Barnes, 1999). TNF-a may have an important 
amplifying effect in asthmatic inflammation and potently stimulates airway epithelial 
cells to produce cytokines (Chung and Barnes, 1999). Increased levels of TNF-a 
have been detected in sputum, BALF and biopsy samples from asthmatic patients 
(Kips, 2001). Since we have shown that the cell viability of HMC-1 cells was always 
greater than 80% with the studied concentrations of extract, the inhibition of cytokine 
production in HMC-1 should not be due to the toxicity of the herb extract. Therefore, 
we speculated that inhibition of inflammatory cytokines was a potential mechanism 
119 
Chapter 5 
of Kuan Dong Hua for asthma treatment. 
Cytokine secretion by human mononuclear cells can be induced by endotoxin 
(Chang et al.，1995; Zhao et al” 2005). Perhaps endotoxin may affect the secretion of 
cytokines in this study. In this study, the effect of endotoxin contamination in the 
herb extract was checked by measuring endotoxin levels using a LAL test, and 
moreover, by adding polymyxin B, an endotoxin inhibitor, to the highest 
concentration of extract to see whether the inhibitory effects of cytokine secretion 
were altered. The results showed that the endotoxin levels in the extract were 
undetectable. Furthermore, the secretion of IL-6, GM-CSF and TNF-a did not differ 
significantly with or without addition of PMB except that the inhibition of IL-8 
release by the extract was significantly suppressed by PMB. Despite this observation, 
the inhibitory effect of IL-8 was still significant at 24 h with addition of PMB. 
Therefore, the ability of Kuan Dong Hua to inhibit the secretion of these cytokines 
was not caused by endotoxin contamination. 
In conclusion, our results showed that Kuan Dong Hua has an inhibitory effect 
on the PMA plus A23187-induced production of IL-8, GM-CSF and TNF-a from the 
HMC-1 cells in vitro. The therapeutic activity of Kuan Dong Hua on asthma may be 
partly related to its modulation of the inflammatory cytokine release from mast cells. 
However, further studies are required to confirm the effect and the precise 
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Figure 4-1. Effect of Kuan Dong Hua on the viability of HMC-1 cells. Cell viability 
was evaluated by MTT assay 24 hours after stimulation with 50 ng/ml PMA plus 2.5 
X 10-7 M A23187 in the presence of various concentrations of Kuan Dong Hua 
solution. Results were expressed as percentage of viability relative to the untreated 
stimulated cells, which was set at 100%. Unstimulated cells were neither incubated 
with extract nor stimulated with PMA plus A23187. Data are expressed as the mean 
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Figure 4-2. Inhibitory effects of Kuan Dong Hua extract at concentrations of 0.625, 
1.25 and 2.5 mg/ml on the PMA plus A23187-stimulated (A) IL-6, (B) IL-8, (C) 
GM-CSF and (D) TNF-a release from HMC-1. Cells (1 x loVwell) were 
preincubated with Kuan Dong Hua extract for 1 h before stimulation with 50 ng/ml 
PMA plus 2.5 X 10-7 M A23187 for 6 and 24 h. The cells treated with 2.5 mg/ml of 
extract were also combined with 100 U/ml of PMB, an endotoxin inhibitor. Results 
were calculated as percentage of inhibition of cytokine release with reference to the 
untreated stimulated cells, which was set at 100%. Data are expressed as the mean 士 
SEM of triplicate determinations from three independent experiments. Statistical 
analysis was performed using the Student's unpaired Mest. *?<0.05, **P<0.0\ 
compared with the PMA plus A23187-stimulated cells. "^?<0.05,卞卞i^ O.Ol compared 






Our previous study has shown that an innovative Chinese herbal formula CUF2 
has beneficial anti-inflammatory effects in an ovalbumin-induced rat model of 
asthma (Wong et al” 2006)，but the efficacy of the individual ingredient has not been 
well characterized. In this study, we have explored the anti-inflammatory and 
anti-asthmatic effects of each of the four ingredients in CUF2 (Huang Qi, Bai Bu, 
Chuan Bei and Huang Qin) in a HDM-induced rat model of asthma. The fifth 
component Dong Chong Cao was not studied because our preliminary study on this 
herb gave unsatisfactory results (unpublished data). Instead, another herb Kuan Dong 
Hua which is commonly used in TCM to treat asthma and was shown by other 
researchers to have anti-inflammatory effects in asthmatic patients (Lee et al., 2004) 
was included in the study. Both in-vitro and in-vivo studies of this herb have been 
performed. 
The first part of this study was to establish an animal model of HDM-induced 
asthma in SD rats. SD rats after i.p. and s.c. sensitization to HDM antigen (Der f ) on 
days 1 and 3 were challenged intratracheally with HDM on days 18，24, and 30. We 
have shown that repeated HDM challenges induced allergic inflammation in 
sensitized rats with characteristic of human disease. The total inflammatory cells 
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count and eosinophil number in BALF were significantly increased in the asthma 
group compared with control. Moreover, histological examination of lung tissue 
showed obvious peribronchial and perivascular cell infiltrates, consisting primarily 
of lymphocytes and eosinophils, as well as a marked goblet cell hyperplasia in the 
asthma group. Furthermore, the HDM-induced inflammation was accompanied by an 
increased production of cytokines and chemokine (IL-4, IL-6, IL-10, TNF-a, IFN-y, 
and MCP-1) in BALF which may be important in mediating the inflammatory cell 
infiltration. We have described an asthmatic model which displays the basic 
characteristics of allergic asthma. This animal model will allow further investigations 
of the pathogenesis of HDM-induced asthma and the potential therapeutic agents of 
asthma. 
In the second part of the study, we investigated the anti-inflammatory and 
anti-asthmatic effects of each of the herb extract, Huang Qi, Bai Bu, Chuan Bei, 
Huang Qin and Kuan Dong Hua in the established HDM-induced allergic asthma 
model. In this model, the herb extract was administered daily for 22 consecutive days, 
beginning 1 day after the second HDM sensitization. With the exception of Chuan 
Bei which was shown to reduce total cellularity in BALF, all other herbs had no 
significant effect in the total cell number and eosinophil in BALF. The lung histology 
also showed that all the herbs had no effect on the inflammatory cell infiltration, 
airway eosinophilia and goblet cell hyperplasia. Despite no apparent effect on cell 
counts in BALF and lung tissue, these herbs exerted inhibitory effects on cytokines 
and chemokine production in BALF. Kuan Dong Hua significantly inhibited IL-4, 
IL-6, IL-10 and MCP-1. Huang Qi and Bai Bu showed some efficacy in reducing the 
IL-4 production. In addition, Chuan Bei and Huang Qin significantly inhibited 
126 
Chapter 5 
MCP-1 and IL-10 respectively. Owing to their immunomodulatory activity, these 
herbs may have potential benefits in treating asthma. However, more studies are 
required to provide evidence of the therapeutic efficacy of these herbs. As expected, 
pretreatment with DXA, which was used as a positive control, completely blocked 
the inflammatory response and suppressed thymus and spleen index in this model, 
but with severe body weight loss. In contrast to the overall immunosuppressive 
effects of DXA, none of the herb treatments significantly affect IFN-y production, as 
body weight, or thymus and spleen index. 
In the last part of the study, we aimed to investigate the anti-inflammatory effect 
of Kuan Dong Hua in-vitro using the human mast cells HMC-1. Mast cells are a 
known source of cytokines that are involved in the allergic inflammatory process. 
The inhibitory effect of Kuan Dong Hua on mast cell cytokine production was 
studied. We showed that the extract of Kuan Dong Hua significantly inhibited PMA 
plus A23187-induced production of IL-8, GM-CSF and TNF-a from HMC-1. Our 
results suggest that inhibition of these mast cell-derived inflammatory cytokines may 
explain the therapeutic activity of Kuan Dong Hua in treating allergic diseases, such 
as allergic asthma. 
Both in vitro and in vivo studies have showed that Kuan Dong Hua has potent 
immunomodulatory activity in asthma and this indicates it may be potentially useful 
medicine for asthma. However, further study is required to determine the active 
components of this herb as well as to elucidate the immunomodulatory mechanism. 
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5.2 Limitations of this study and Future work 
There are several limitations in this study which should be addressed. One 
limitation of this study was the high mortality of rats during the procedure of 
intratracheal intubation. This study was therefore limited by the relative small sample 
size of rats. We found that the excess saliva production during intubation was a major 
cause of death. In an attempt to solve this problem, we found that clearing the 
airways by aspiration of the saliva could help to lower the mortality of rats. 
The second limitation is that some essential features observed in human asthma 
have not been demonstrated in our animal model. For example, measurement of the 
serum total IgE (and/or HDM-specific IgE) concentration and bronchial reactivity to 
non-specific (methacholine) and specific allergen challenge in HDM-sensitized rats 
has not been performed. These two measurements are crucial in determining the 
whole clinical phenotype of asthma. Only when they show increased response can 
we confirm that this established model is an animal model of allergic asthma instead 
of solely an airway inflammation model. 
Moreover, without these two measurements, the results of herb extracts in-vivo 
can only provide a partial explanation of their 'anti-asthma' effects of the herbs. In 
other words, the negative results in the cellular infiltration and cytokine production 
could not rule out the possible beneficial effect of these herbs in reducing 
total/HDM-specific IgE as well as BHR. Although BHR is frequently associated with 
inflammatory cells infiltration, BHR may occur independent of airway inflammation 
but related to the response of putative nerve innervations and peribronchial smooth 
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muscle contractility, which may be the major targets of several anti-asthmatic 
extracts (Xiao-Qing-Long-Tong). Such kinds of measurements (i.e. serum IgE and 
BHR) are therefore important in the explanation of the whole mechanisms of the 
anti-asthma effects of the herb extracts. 
The third limitation is about the timing of administration of herb extract. In this 
study, only administration before allergen challenge (preventive protocol) has been 
performed because of time constraint. To evaluate the anti-inflammatory effect of 
herb extracts, we may also need to study the effect of administration after allergen 
challenge (therapeutic protocol) when allergen-induced airway inflammation started 
to build up and peak at later time after allergen challenge. 
Another limitation of this study is that only individual effects of the five 
separate herbal extracts were studied. The synergistic effects of the extracts were not 
studied because of time constraint. Different combinations of these herbal extracts 
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Appendix A. Wright-Giemsa Stain for cytospin preparations 
1) After cytospin preparations were made, they were air-dried thoroughly and fixed 
in absolute methanol for 5 minutes. They were air-dried and stained as described 
below. 
2) They were put in a Coplin jar containing 50 ml Wright-Giemsa stain 
(Sigma-Aldrich) for approximately 30 seconds. 
3) They were removed from the stain and placed in deionized water (pH 6.8-7.2) or 
phosphate buffer, pH 6.8-7.2 for 1-10 minutes. 
4) They were rinsed briefly in running deionized water and air dried thoroughly 
before evaluation. 
Appendix B. Hematoxylin & eosin (H&E) staining 
1) Sections were deparaffinized by three changes of xylene for 5 minutes each, and 
rehydrated through a series of graded alcohols (100%, 95%, 80%, 70% ethanol) 
for 5 min each and then to running tap water. 
2) Stained with Mayer's hematoxylin for 3 minutes. 
3) Washed in running tap water for 1-2 minutes. 
4) Differentiated in 1% acid alcohol for 2 seconds to remove excess stain from 
background, and washed again in running water for 1 minute. 
5) Dipped in Scott's tap water for 30 seconds until the nuclei turned blue, and 
washed again in running water for 1-2 minutes. 
6) Stained with the second dye, eosin for 5 minutes, 
7) After a brief wash in running water, slides were dehydrated quickly through 70%, 
80%, 95% alcohols for 10 seconds each, and then three changes of absolute 
alcohols for 3 minutes each. 
8) Lastly, they were cleared in three changes of xylene for 5 minutes each. 
9) They were mounted with coverslips with a resinous medium, e.g. Permount 
(Fisher Scientific, Fair Lawn, NJ). 
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Appendix C. Congo Red staining 
The procedure was described by Highman in 1946. 
1) Sections were deparafFinized and rehydrated to water as H&E staining. 
2) Stained for 5 minutes in 0.5% (w/v) Congo Red (Sigma, St. Louis, MO) in 50% 
alcohol. 
3) Quickly differentiated in 0.2% (w/v) potassium hydroxide in 80% alcohol for a 
few seconds. 
4) Washed in running water for 1-2 minutes. 
5) Stained in hematoxylin for 3 minutes as steps 2-4 of H&E staining. 
6) Blued in Scott's tap water, dehydrated, cleared and mounted as steps 5，7-9 of 
H&E staining. 
Appendix D. Periodic acid-Schiff (PAS) staining 
1) Sections were deparafFinized and rehydrated to water as H&E staining. 
2) Dipped in 1% (w/v) periodic acid (BDH Chemical, Poole, UK) for 10 minutes. 
3) Washed well with several changes of distilled water to remove any traces of acid. 
4) Placed in Schiff's reagent (Merck) for 32 minutes. 
5) Washed in running tap water for 12 minutes to intensify the colour reaction. 
6) Then, stained for nuclei with hematoxylin for 2 minutes, differentiated in 
acid-alcohol and blueing as steps 2-5 of H&E staining. 
7) Lastly, they were dehydrated, cleared and mounted in Paramount as steps 7-9 of 
H&E staining. 
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